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ABSTRACT
The human body’s intracranial pressure (ICP) is a critical component in
sustaining healthy blood flow to the brain while allowing adequate volume for
brain tissue within the rigid structures of the cranium. Disruptions in the body’s
autoregulation of intracranial pressure are often caused by hemorrhage, tumors,
edema, or excess cerebral spinal fluid resulting in treatments that are estimated
to globally cost up to approximately five billion dollars annually. A critical element
in the contemporary management of acute head injury, intracranial hemorrhage,
stroke, or other conditions resulting in intracranial hypertension, is the real-time
monitoring of ICP. Currently, such mainstream clinical monitoring can only take
place short-term within an acute care hospital. The monitoring is prone to
measurement drift and is comprised of externally tethered pressure sensors that
are temporarily implanted into the brain, thus carrying a significant risk of
infection. To date, reliable, low drift, completely internalized, long-term ICP
monitoring devices remain elusive. The successful development of such a
device would not only be safer and more reliable in the short-term but would
expand the use of ICP monitoring for the management of chronic intracranial
hypertension and enable further clinical research into these disorders. The
research herein reviews the current challenges of existing ICP monitoring
systems, develops a new novel sensing technology, and evaluates the same for
potentially facilitating long-term implantable ICP sensing. Based upon the
findings of this research, this dissertation proposes and evaluates a dual
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matched-die piezo-resistive strain sensing device, with a novel in-vivo calibration
system and method thereof, for application to long-term implantable ICP sensing.

v

TABLE OF CONTENTS
Chapter One Introduction and General Information .............................................. 1
Intracranial Pressure and Disorders Thereof ..................................................... 2
Standard Intracranial Pressure Measurement Techniques ............................... 7
Challenges of Intracranial Pressure Monitoring ............................................... 12
Significance and Contribution .......................................................................... 13
Chapter Two Literature Review........................................................................... 18
Overview ......................................................................................................... 18
Direct ICP Measurement ................................................................................. 18
Direct Fiber Optic Measurement .................................................................. 20
Direct Microstrain Measurement .................................................................. 23
Other Direct Techniques and Modern Approaches ...................................... 28
Indirect ICP Measurement ............................................................................... 30
Non-Invasive ICP Assessment ........................................................................ 33
ICP Telemetric Approaches ............................................................................ 37
Raumedic Neurovent-P-tel........................................................................... 41
Meithke Sensor Reservoir............................................................................ 43
Research Gap and Limitations ........................................................................ 47
Chapter Three Materials and Methods................................................................ 49
Overview ......................................................................................................... 49
Requirements .................................................................................................. 50
Approach ......................................................................................................... 55

vi

Sensor Technology ...................................................................................... 55
Sensor System Design ................................................................................ 82
Deployment and Implantation ...................................................................... 93
Electronics Readout Overview ..................................................................... 97
Methods ........................................................................................................ 103
Simulation .................................................................................................. 103
Sensor Evaluation...................................................................................... 104
Uncorrected Sensor Drift Assessment ....................................................... 104
System Calibrated Sensor Assessment ..................................................... 106
Chapter Four Results and Discussion............................................................... 114
Sensor Simulations ....................................................................................... 115
Uncorrected Sensor Drift Results .................................................................. 122
System Calibrated Sensor Results ................................................................ 132
Non-Ideal Effects and Challenges ................................................................. 165
Chapter Five Conclusions and Recommendations ........................................... 183
List of References ............................................................................................. 189
Appendix ........................................................................................................... 204
Vita.................................................................................................................... 209

vii

LIST OF TABLES
Table 1 – Non-Invasive ICP Approaches ............................................................ 36
Table 2 – Key Requirements and Research Objectives Summary ..................... 56
Table 3 - Low power instrumentation amplifiers ................................................ 102
Table 4 – Sensor bridge piezoresistance at 22.1°C .......................................... 116
Table 5 – Sensor Pressure Range Verification ................................................. 141
Table 6 – Sensor resolution summary .............................................................. 143
Table 7 – Accuracy measurements for sensors U1 and U2, n=100 .................. 144
Table 8 – System calibrated dual matched-die sensor results at gain ±20% .... 152
Table 9 - System calibrated dual matched-die sensor results for induced offset
................................................................................................................... 154
Table 10 – Power consumption of transponder’s main components. ................ 163
Table 11 – Transponder primary component volumes ...................................... 165
Table 12 – Sensor and supporting substrate cavity volume.............................. 169
Table 13 – Research Objective Fulfillment ....................................................... 186

viii

LIST OF FIGURES
Figure 1 – CSF generation within the brain. .......................................................... 3
Figure 2 – Axial MRI showing enlargement of the lateral ventricles due to
elevated ICP. ................................................................................................. 5
Figure 3 - Intracranial pressure monitoring with a ventricular catheter.................. 8
Figure 4 – Fiber optic pressure sensor. .............................................................. 10
Figure 5 – Thermal map of primate brain for two frontal sections (14.3 and 0.3).
..................................................................................................................... 22
Figure 6 - Illustration of various ICP measurement techniques. .......................... 32
Figure 7 – Transponder described by Atkinson et. al. [84] .................................. 38
Figure 8 - Raumedic NEUROVENT-P-tel [38] .................................................... 42
Figure 9 - The Miethke SENSOR RESERVOIR .................................................. 44
Figure 10 – Conventional metallic micro-strain resistive pattern. ........................ 62
Figure 11 – Wheatstone pressure transducer comprising strain sensors. .......... 67
Figure 12 - TE Connectivity 1630........................................................................ 70
Figure 13 – Amphenol All Sensors 30 INCH-D-MV pressure sensor die,
approximately 2 mm2. .................................................................................. 73
Figure 14 – 30 INCH-D-MV side view at 40X (photo border provided for clarity) 76
Figure 15 - Amphenol sensor die deployment upon ceramic PCB with
soldermask. ................................................................................................. 76
Figure 16 – Laser trimmed film compensation resistors...................................... 77
Figure 17 – Amphenol published equivalent circuit. ............................................ 81
Figure 18 – Derived Wheatstone bridge pressure sensor model. ....................... 81
ix

Figure 19 – Illustrative cross-section concept of dual pressure sensors with each
P1 and P2 cross-coupled to top-side and bottom-side dies. ........................ 83
Figure 20 – Cross coupled dual sensor configuration for error compensation. ... 85
Figure 21 - Independent dual sensor with absolute reference configuration for
error compensation. ..................................................................................... 87
Figure 22 – Independent output dual sensors with common power/bias rails. ... 87
Figure 23 – Biopressure transponder deployment with ventricular catheter. ...... 88
Figure 24 – Alternative transponder deployment with fluid bladder as a
parenchyma pressure transducer. ............................................................... 90
Figure 25 – System deployment of biopressure sensor with reference fluid
column and shunt integration (shunt peritoneal catheter shown). ................ 92
Figure 26 – Transponder and readout deployment block diagram. ..................... 96
Figure 27 – Operational amplifier differential configuration. ................................ 98
Figure 28 – Instrumentation amplifier................................................................ 100
Figure 29 – Long term drift chamber with external and local power supply
regulation and thermal stability with data acquisition system under UPS. . 105
Figure 30 – Front-end circuit for long-term cross-coupled sensor assessment. 107
Figure 31 – Dual biopressure sensor test bench with pressure source, precision
power supply, instrumentation amplifier, and oscilloscope measurement. 108
Figure 32 – Isolation chamber with self-contained pressure source for offset
testing. ....................................................................................................... 110
Figure 33 – Front-end circuit for benchtop testing of system calibrated sensor.
................................................................................................................... 111
x

Figure 34 – Piezoresistor temperature response .............................................. 117
Figure 35 – Sensor bridge PSPICE simulation circuit for piezoresistor mismatch
and temperature sweep. ............................................................................ 118
Figure 36 – PSPICE simulation showing piezoresistance for R1 at 20°C, 36°C,
37°C, 38°C, and 40°C. ............................................................................... 119
Figure 37 - PSPICE simulation showing bridge output of 329.076 μV for all
temperatures 20°C - 40°C. ........................................................................ 120
Figure 38 – Temperature gradient from sensor’s Joule heating upon 37°C CSF.
................................................................................................................... 122
Figure 39 – Laboratory setup for uncorrected long-term drift measurement of
cross-coupled sensor. ................................................................................ 124
Figure 40 – Long-term test sensor with pressure cylinder and read-out circuit. 125
Figure 41 – Uncorrected pressure sensor initial transfer function. .................... 126
Figure 42 – Long-term uncorrected pressure sensor drift for 31 mm H2O liquid
(BLVR-L30D-B1NS). .................................................................................. 128
Figure 43 - Uncorrected pressure sensor initial and 2.5-year transfer function. 129
Figure 44 – Six-month drift results for dual pressure sensor build 0517 ........... 131
Figure 45 – Custom dual biopressure sensor exploded illustration. .................. 133
Figure 46 – Custom dual matched die biopressure sensor prototype showing
absolute reference chamber and top-side dies therein. ............................. 135
Figure 47 - Custom dual matched die biopressure sensor prototype showing both
independent chambers and top-side reference chamber. .......................... 137
Figure 48 – Custom dual matched-die sensor readout circuit. .......................... 138
xi

Figure 49 – Custom dual biopressure sensor transfer function (Build 0517). ... 139
Figure 50 - +502 mm H2O signal ...................................................................... 142
Figure 51 - -499 mm H2O signal ....................................................................... 142
Figure 52 – Accuracy measurement for sensor U1, 150 mm H2O, n=100 samples
................................................................................................................... 145
Figure 53 - Accuracy measurement for sensor U2, 150 mm H2O, n=100 samples
................................................................................................................... 145
Figure 54 – Precision measurement histogram for 150 mm H2O and n = 100 .. 147
Figure 55 - Dual sensor die comparison for 80%, 100%, and 120% gain. ........ 148
Figure 56 – Custom dual biopressure sensor system test bench. .................... 149
Figure 57 – Reference reservoir for liquid fluid column. .................................... 150
Figure 58 - Isolation pressure chamber with self-contained pressure source. .. 150
Figure 59 – Vacuum pressure chamber measurement ..................................... 156
Figure 60 – System calibrated dual sensor performance for 100 mm H2O and
induced gain shift. ...................................................................................... 157
Figure 61 - System calibrated dual sensor performance for 150 mm H2O and
induced gain shift. ...................................................................................... 158
Figure 62 - System calibrated dual sensor performance for 150 mm H2O and
induced offset shift. .................................................................................... 159
Figure 63 – 5V front-end circuit design with Vo of 0-3.08 V supporting TI CC2541
................................................................................................................... 161
Figure 64 – Initial outgassing of polyvinyl chloride (PVC) tubing. ..................... 168

xii

Figure 65 – Bubble formation and air voids from advanced outgassing of tubing.
................................................................................................................... 168
Figure 66 – Sensor cavity air-liquid transfer and bubble formation. .................. 170
Figure 67 – COMSOL axisymmetric pressure gradient..................................... 174
Figure 68 - COMSOL axisymmetric water vapor concentration. ....................... 174
Figure 69 - COMSOL axisymmetric water volume fraction. .............................. 175
Figure 70 - COMSOL axisymmetric fluid velocity. ............................................. 175
Figure 71 – Top-side die metal migration from liquid media contact. ................ 178
Figure 72 – Custom dual biopressure sensor absolute reference temperature
response. ................................................................................................... 180

xiii

CHAPTER ONE
INTRODUCTION AND GENERAL INFORMATION
The human body is comprised of various organs that generate, or are subject to,
a variety of pressures. These pressures are primarily induced externally due to
gravity and include atmospheric compression and body weight opposition.
However, there are also a wide range of pressures induced within the body itself.
These pressures include those generated by the cardiovascular system, urinary
system, digestive tract, musculoskeletal system, central nervous system, among
others. Most of these pressures are critical for good health and require precise
regulation. Blood pressure within the cardiovascular system and intracranial
pressure (ICP) within the central nervous system, arising from the generation of
cerebral spinal fluid (CSF), are two such components that must be precisely
maintained. The ability to continuously monitor these pressures would allow for
early detection and intervention in the event autoregulation becomes impaired.
To date, long-term ICP sensing remains a challenge, primarily due to sensor
inaccuracies over long periods of time.
With the advancement of micro-electro-mechanical system (MEMS) elements,
low power inductively charged electronics, standardized wireless methods, as
well as wireless hand-held computing devices, it has recently become feasible to
potentially realize long-term telemetric implantables for physiological monitoring.
ICP pressure is one such candidate that is desirable for telemetric monitoring. It
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is among the most critical pressures found within the body whereby intracranial
hypotension can lead to ruptured blood vessels and hematomas while
hypertension can lead to decreased blood perfusion within the brain. Either case
is quickly life threatening and affects one- to two-percent of the population
congenitally by hydrocephalus, or is acquired due to brain tumor, traumatic brain
injury, or from arachnoid villi damage from meningitis, for example. The work
herein seeks to overcome the challenges of ICP monitoring where highresolution pressures, on the order of several millimeters of water, must be
measured in-vivo with low drift over long periods of time (e.g. years). This
research undertakes a review of the scientific literature to assess the current
challenges of ICP monitoring and to develop a new novel approach for
overcoming the fundamental limitations of long-term implantable ICP sensing,
particularly measurement drift. The goal of this work is for the research and
initial evaluation of a novel biopressure sensor system to serve as a platform
technology for accurate and clinically relevant long-term measurements of ICP.

Intracranial Pressure and Disorders Thereof
Pressure within the cranium is due to the arterial and venous pressure acting
against the pressure head of the intracranial contents. Blood flow to the brain,
characterized by cerebral perfusion pressure (CPP), is commonly calculated
using ICP and mean arterial pressure (MAP) using the relationship CPP = MAP –
ICP. Intracranial pressure is normally generated primarily from the formation of
cerebral spinal fluid (CSF) and is a result of the pressure-volume relationship of
2

incompressible fluids within the semi-rigid intracranial compartment. Therefore,
any changes in the volume of the intracranial contents alters ICP. CSF is
primarily formed by the choroid plexus within the first and second lateral
ventricles of the brain, illustrated in Figure 1, where it thereafter flows into the
third and fourth ventricles. Flowing from the ventricles, CSF then surrounds the
spinal cord and subarachnoid space, where it is reabsorbed by the arachnoid
villi. CSF pressure varies in human beings, but generally falls within the range of
68 to 136 mm H2O in normal adults in the recumbent position [1, 2] although
some clinicians cite normal pressures as high as 180 mm H2O or 200 mm H2O
[3, 4]. In the upright position, ventricular pressure is typically around atmospheric
(i.e. ~0 mm H2O) or even negative due to gravitational forces upon the spinal
fluid column [4].

Figure 1 – CSF generation within the brain.
(Source: Gray's Anatomy of the Human Body, 20th edition)
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Abnormalities occur when there is an over generation of CSF by the choroid
plexus or a malabsorption of the fluid by the arachnoid villi, such as that with
hydrocephalus. Abnormal pressures can also result when restrictions or
obstructions in the fluid pathway retard or prevent CSF reabsorption. These
obstructions can often be congenital but may also result from brain tumors or
head trauma. Figure 2 shows an axial MR brain scan where enlargement of the
lateral ventricles has occurred as a result of abnormally high ICP.
Koskinen showed that for pathological patients under study in the neuro-ICU,
patients’ average ICP was 249 mm H2O, measured intraventricularly [5]. For
hydrocephalus patients, who suffer from chronic intracranial hypertension (ICH),
a CSF shunt is the most common treatment for maintaining normal pressure
levels and for preventing dangerously high levels of ICP. A shunt diverts excess
CSF to a resorptive site, commonly in the peritoneum, within a small catheter
lumen including a pressure threshold check valve. Without a shunt, or
equivalently in the case of a failed shunt (e.g. due to an obstruction), a patient’s
condition may quickly become life threatening as ICP overcomes MAP, thereby
restricting CPP. Short of other interventions, such as 3rd ventriculostomy or
temporary external ventricular drainage, untreated hydrocephalus is typically fatal
[6, 7].
Lundberg additionally indicated severe ICP has been shown to extend even
beyond 500 mm H2O [8]. Young reported extreme ICP levels in excess of
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Figure 2 – Axial MRI showing enlargement of the lateral ventricles due to
elevated ICP.
(Source: Neurosurgery Center of Colorado)
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680 mm H2O for severe head trauma patients who were provided atypical
specialized treatments to maintain CPP above 60 mm Hg with notable success
[9]. Nevertheless, for patients whose ICP exceeded 1,019 mm H2O (i.e. 75 mm
Hg), Young reported brain herniation and fatal outcomes within 24 hours.
Regardless, the case studies by Young with ICP’s above 500 mm H2O represent
acute head trauma cases and not chronically elevated ICP’s typically associated
with hydrocephalus.
Typical methods for assessing intracranial pressure require a surgical procedure
to install a ventricular catheter through the skull and thereafter measuring CSF
pressure with an external manometer. Another method involves the use of a
tethered electrical or optical pressure sensor that can be inserted into the brain
for localized in-vivo readings. For example, optical pressure sensors are
commercially available with a pressure transducer located at the tip of a fiber
optic strand. Fiber optic instrumentation is used to provide pressure read outs
based upon interferometer techniques to detect translation of the pressure
transducer’s diaphragm.
While these methods provide in-situ assessment of intracranial pressure, they do
so most invasively and only upon a temporary basis within a surgical or intensive
care setting. Typically, these types of pressure measurements are only carried
out after a variety of other expensive diagnostics, such as medical imaging, have
been exhausted in an attempt to explain the root cause of a patient’s illness.
Once it is determined to proceed with invasive pressure measurements, the
6

patient is often sedated while the sensing element is surgically installed.
Thereafter, the pressure sensor element remains temporarily tethered to the
patient through a bore hole in the skull. It is then necessary to place the patient
under continuing hospital care in order to monitor the pressure over time.
Therefore, these assessment techniques are unfortunately the most invasive and
expensive approach possible. They furthermore increase patient risk with the
potential of surgical complications, such as infection, especially over prolonged
periods [10]. Since intracranial pressure can rapidly rise due to an adult’s fixed
intracranial volume, patients can quickly reach a critical state by the time all
preliminary diagnostics have proven negative. Therefore, a need exists for high
risk patients to be able to routinely and non-invasively monitor ICP to prevent life
threatening emergencies and to allow further research into ICP under various
conditions or activities. The work of this dissertation seeks to advance the field
of research of this problem by investigating the limiting factors preventing longterm ICP monitoring and potential solutions thereof.

Standard Intracranial Pressure Measurement Techniques
The “gold standard” method of assessing ICP is through the introduction of a
catheter, connected to a manometer, into the ventricles of the brain by way of a
bore hole though the skull, as shown in Figure 3 [11]. A saline solution is used, if
needed, as a translating fluid medium to allow external alignment of the
measuring solution with that of the ventricular cavity. Fluid elevation beyond that
of the internal cavity ceiling level is then measured to arrive at a pressure relative
7

Figure 3 - Intracranial pressure monitoring with a ventricular catheter.
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to atmospheric. This technique allows for robust pressure measurement that is
immune to drift and which also facilitates drainage relief as necessary. However,
the method is also the most invasive of all techniques with studies indicating up
to an approximate 10% infection rate [12, 13].
A popular alternative to manometer pressure measurements is that provided by
optical pressure transducers, such as those marketed by FISO [14] or Natus [15].
In this technique, a fiber optic strand with a pressure sensitive tip is inserted into
a ventricular catheter or into the parenchyma and is read out by interferometer
instrumentation bedside to the patient. Figure 4 shows such a fiber optic sensor
whereby the strand is configured with a pressure sensitive membrane that
translates relative to incident pressure. A collimated light source present within
the fiber and reflecting off the sensor membrane varies the amount of reflective
constructive or destructive interference. Therefore, the amplitude of the reflected
light received at the proximal end is proportional to the pressure present upon the
membrane tip. Drift and temperature effects have been widely reported with
such sensors, however [2, 11].
Since the fiber optic method is optically based, using interferometry against an
absolute pressure reference, and given there are no present devices with
temperature sensing and correction, the pressure drifts with temperature. Drift
reported for fiber optic pressure sensors may predominately be due to the sensor
being “zeroed” ex-vivo at room temperature and then actual pressure
assessments taken in-vivo at a temperature of approximately 37°C. Additionally,
9

Figure 4 – Fiber optic pressure sensor.
(Source: Sensors by Questex Media Group LLC)
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since these types of sensors typically deflect more than the thickness of the
pressure diaphragm itself in order to reach desired sensitivities, the diaphragm
operates within a non-linear range of deflection, which can extend into plasticity
and result in hysteresis. Piper reported that their data indicated more than half of
34 fiber optic pressure transducers explanted had zero drift in excess of 40 mm
H2O [11].
In addition to fiber optic pressure readout systems, additional prevailing
techniques include the use of an implantable strain gauge inserted into the
brain’s ventricles or parenchyma. Commercial offerings, such as those
manufactured by Codman (under Integra Life Sciences) [16], offer a titanium
probe with a side sensor providing electrical communication of pressure from the
transducer to a bedside readout system. The Codman sensor consists of a solid
state piezoresistive diaphragm and a Wheatstone bridge readout circuit [2]. As
pressure modulates the diaphragm, induced strain changes the resistive
properties of the material. The Wheatstone circuit converts this variable
resistance into a proportional electrical current representative of the sensor’s
incident pressure. Advantages of this silicon technique include the option of
temperature compensation based upon in-vivo silicon bandgap measurements.
Assessments of the Codman strain-based sensor (also referred to as a
microstrain device) have shown minimal drift, an average of 12 mm H2O, and
with pressures that correlate accurately with direct intraventricular ICP
measurements [2, 5].
11

While other methods of ICP exist, including qualitative non-invasive techniques
discussed within the Literature Review, the formerly described intraventricular
catheter manometer, fiber optic sensor, and strain gauge sensor comprise the
extent of prevalent and contemporary means of quantitative clinical assessment.

Challenges of Intracranial Pressure Monitoring
The primary challenge of monitoring ICP is accuracy balanced against risk. The
most accurate methods are invasive, ranging from lumbar puncture to various
cranial access approaches, including ventriculostomy. Accuracy is diminished by
pressure sensor drifts, which have been shown to range from 1 - 3 mm Hg (14 –
41 mm H2O) in just five days, significantly reducing clinical efficacy, especially for
longer term use [29]. Lumbar puncture has severe limitations with accuracy [17].
Ventricular cannulation remains the gold standard for the most accurate ICP, but
carries the highest risks, which are associated with brain penetration (e.g.
placement, hemorrhage, etc.) and infection. Infection rates for a ventriculostomy
currently range from 8 – 10% [12, 13]. However, rates for intraparenchymal
sensing reside at approximately only 1 - 2% [18]. Other invasive methods, such
as subarachnoid, subdural, and epidural devices have proven unreliable and are
not commonly used in clinical practice [19]. In all invasive methods, with
exception to telemetric sensors which are also currently limited in accuracy, the
sensor is tethered to a bedside receiving unit, limiting ambulation and increasing
infection risks. With regard to non-invasive approaches, all are currently
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qualitative, at best, as Robba recently summarized, there were no prevailing noninvasive techniques to justify substituting for current invasive approaches [20].

Significance and Contribution
Hydrocephalus is presently reported to congenitally afflict between 0.5 to 3 out of
every 1,000 live births [21, 22, 23, 24]. However, the disorder can also be
acquired from pathologies such as brain tumors, head injury, meningitis, or as a
result of intracranial hemorrhage, which altogether represents about 40% of all
cases [25]. Procedural statistics from the American Association of Neurological
Surgeons (AANS) estimated approximately 70,000 U.S. shunt procedures were
performed in 2011 while the Hydrocephalus Association currently reports over
one-million people in the U.S. are living with the disorder [24, 26]. Procedural
costs in the U.S. have been estimated at an average $35,816 per admission
thereby placing the total cost burden in the U.S. into the billions of dollars
annually [27].
Although credited to Nulsen and Spitz in 1951 for the first fully internalized shunt,
Richard Ames initiated what has now became the most prevalent shunt of
modern times when he first implanted the ventriculoperitoneal (VP) shunt in 1958
comprised of silicone rubber [28]. Silicone was first implanted via a shunt by
Pudenz in 1957 for the lesser common, at least in the U.S., ventriculoatrial shunt
[29]. Nine years thereafter Ames reported promising results, for an otherwise
typically fatal disorder, indicating successful VP shunt implants in an additional
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120 patients [30]. Still today, shunts are the predominant lifesaving treatment for
hydrocephalus, yet unfortunately have about a 50% failure and revision rate by
the second year of implantation and 70% to 88% by year ten [31, 32, 33, 34].
Shunt failure is commonly associated with the onset of a headache and can
thereafter quickly turn lethal [35, 36]. However, headaches are also typical of
shunt mis-adjustment resulting in either under-drainage or over-drainage. Antes
et. al. recently described that shunt malfunction, as well as under- or overdrainage, is difficult to diagnose and with shunt radiography and cranial imaging
often remaining inconclusive [37, 38]. The problem is further aggravated when a
patient is not in a state to sufficiently describe their symptoms. Verification of
intracranial pressure then entails costly and risky invasive techniques for the
measurement of ICP, as described in detail within the Literature Review. Such
invasive techniques are the only current and clinically accurate means of
assessing ICP, either for shunted patients suspected of shunt malfunction or for
patients initially succumbing to intracranial hypertension for other reasons (e.g.
brain trauma, lesions, edema, hemorrhage, etc.).
The benefits of being able to accurately and telemetrically measure ICP are
numerous and immense. Within the literature, many investigators have
considered ICP-guided valve adjustments by using telemetric ICP measurements
as one of the most forward-looking advancements in hydrocephalus
management [39, 40, 41]. Benefits are obvious for diagnosing potentially
dangerous, yet unspecific headaches, particularly for those whose clinical
14

symptoms cannot be easily correlated to over drainage or underdrainage [42].
Authors have cited a long-standing need for telemetric ICP technology which
would reduce costly imaging dependency for patient monitoring and obviate the
need for additionally implanted shunt devices [43, 44]. Furthermore, ICP
surveillance for patients who have suffered from traumatic brain injury (TBI) has
been one of the most intended indications for long-term ICP measurement.
Latent ICP peaks and the development of secondary hydrocephalus could be
recognized earlier with regular monitoring to reduce the chances of further brain
damage [37]. Moreover, verification of shunt alternatives, such as endoscopic
third ventriculostomy (ETV) could be more efficiently enabled to distinguish ETV
responders versus non-responders as shown by several recent case studies [37].
As shown in the Literature Review, pressure measurement accuracy has been,
and remains, the limiting factor for the deployment of a long-term ICP device.
Even for clinically current mainstream tethered devices, such instrumentation is
limited by so-called “zero drift” even though it may be from baseline or sensitivity
drift, or both. Drifts of 1-3 mm Hg (i.e. 14 – 41 mm H2O) have been reported over
the course of just five days for prevailing ICU tethered instrumentation,
diminishing clinical usefulness [45]. Recent commercial attempts for wireless
ICP sensor implants have validated the needs of the market for telemetric ICP
assessment. However, clinical reviews of the commercialized technology have
shown that marked and unpredictable drifts in accuracy limit broad use,
rendering such implantable sensors unreliable over the long-term [38].
15

Nonetheless, these reviews state that effective ICP monitoring over long periods
outside the clinic is highly desirable and beneficial for optimizing treatment. In a
2016 review, Robba summarized there were no then-current non-invasive
techniques accurate or established enough to substitute for current invasive
measurements [20]. Subsequent reviews of the literature and industry performed
herein have concluded the same, as of time of writing.
Long-term pressure sensor drift is the persistent culprit that prevents the muchneeded diagnostics for millions of people suffering from hydrocephalus, traumatic
brain injury (TBI), and other causes of intracranial hypertension. A recent paper
reviewing the challenges and state of the field for enabling chronically
implantable pressure sensors found it crucial to have a means of drift
compensation circuits or zeroing functions to provide correction [46]. Described
and researched herein is a novel solution for non-invasive offset and gain
calibration based upon dual matched biopressure sensors utilizing an in-vivo
hydraulic reference for negating sensor drift. The research described herein
resulted in the award of United States patent 9,668,663, having been reviewed,
in light of the prior art, for novelty, inventive step, and utility [47]. The device and
method utilizes two matched silicon piezoresistive strain sensors and a common
gas reference to facilitate corrected ICP measurement by one sensor based
upon an in-vivo reference measurement from the other. The device confronts
reference degradation and other sources of potential drift in common-mode to
first reduce drift and then to leverage matched sensor die characteristics for
16

applying correction coefficients measured by one sensor for application to the
other. Deployment of the sensor would allow forthcoming patients to calibrate
the wireless sensor by either using a two-position method (e.g. supine to upright)
or by utilizing natural changes in barometric pressure.
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CHAPTER TWO
LITERATURE REVIEW
Overview
Over the past decade several authors, including Wiegand [17] and Raboel [48],
have provided comprehensive reviews of the methods and instrumentation for
measuring ICP. Hawthorne and Piper [49] published an extensive review in 2014
focusing upon ICP for traumatic brain injury (TBI), including historical
perspectives citing Alexander Monro’s (1697–1767) original publications on
intracranial contents. In 2017, Zhang et. al. [18], published what is today’s latest
review, covering a growing set of research earnestly seeking improvements in
ICP instrumentation. The literature review herein summarizes the present
technological state of ICP instrumentation, extending beyond the latest published
reviews, with a particular emphasis on the research and development of
completely implantable transponder approaches. This chapter organizes the
literature survey into both direct methods for measuring ICP (all of which are
invasive or initially invasive) and indirect methods in which physiologically related
measurements may be proportional to actual ICP.

Direct ICP Measurement
Early direct measurement techniques for assessing ICP was pioneered by
Lundberg and described in his landmark 1960 publication [8] for the continuous
pressure monitoring of 130 patients. His technique employed a saline based
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subdural pressure transducer deployed via ventricular cannulation. Wiegand,
Raboel, Hawthorne, and Zhang all ascribe intraventricular monitoring as the
enduring gold standard of modern day accurate ICP measurement. Zhang’s
assessment attributed invasive methods, such as intraventricular monitoring, as
the most accurate of measuring ICP. Nevertheless, all agree of its shortcomings
with regard to infection rates over time, the potential for brain hemorrhage, and
the difficulty of successfully performing a ventriculostomy under elevated ICP
where a deviated or slit ventricle may be present.
Alternatively, modern day electrical based pressure probes may be utilized such
as the fiber optic [15] or electrical impedance strain transducer [16]. These
sensors can be used either within the ventricle or the parenchyma. Luerssen
described that these modern-day parenchymal sensors are comparable with that
of the intraventricular hydrostatic methods and that the complication rate is lower
due to the small diameter of the probes and lack of fluidic coupling [50].
Luerssen cites Pople [51] and Shapiro [52] as two large studies resulting in less
than a one-percent infection rate for pressure measurements taken within the
parenchyma. For ventricular cannulation, however, Luerssen cites several
studies indicating infection rates approaching ten percent [12, 13]. He describes
the risks of infection increasing with duration of monitoring and for this reason
should only be used for as brief a period as possible. He further cited studies
showing that prophylactically changing the ventricular catheter used for pressure
measurement did not reduce the risk of infection.
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Direct Fiber Optic Measurement
Fiber optic pressure transduction utilizes a thin diaphragm, often constructed
from a silica fiber itself, comprising a sealed cavity in order to measure
diaphragm deflections from incident pressure against an absolute pressure
source. Optical interferometric techniques are used in order to measure the
diaphragm translation. Piper et al. questions, however, the efficacy of the fiber
optic parenchymal or intraventricular pressure probes as a means of accurate
direct measurement. Their research found drifts for the Camino fiber optic
system in excess of 40 mm H2O for 50% of the pressure probes tested within a
period of days [11]. While the manufacturer of the sensor studied specifies an
upper bound on drift of ±27 mm H2O for day one and 13.6 mm H2O for each day
thereafter, Piper claims this is unacceptable for clinical use. Further, researchers
have even confirmed zero drift in excess of the specifications, with average daily
drifts of 43.5 mm H2O, in a study of 136 Camino fiber optic sensors [53]. Such
large drifts were also found in an additional study of 1,000 clinical cases utilizing
the Camino monitor with 87% of the cases drifting from -231 mm H2O to 285 mm
H2O over a mean period of only 58 hours [54].
The study by Piper et. al. showed significant drift bias with a dependence on
temperature for the fiber optic sensor. Studies have indicated a potential reason
for such clinical drift is that the absolute pressure sensors are calibrated (i.e.
“zeroed”) ex-vivo at room temperature (e.g. ~20°C) and then measured in-vivo at
body temperatures, typically at 37°C [55]. A temperature coefficient of 4 mm
20

H2O per °C likely results in a significant pressure error versus the calibration [11].
For a 17°C temperature shift, a 68 mm H2O error would result. However, once in
the brain, temperatures are relatively stable. Figure 5 illustrates temperature
measurements taken in over 100 sites in 16 monkeys involving 347 experiments
[56]. The values shown are site temperature measurements less aortic arterial
blood temperature (all positive values). From the brain’s surface to its ventricles,
a gradient of 0.4°C was documented. Brain temperatures shifts were found to
overall closely track venous blood in the right atrium. From sleep to arousal,
brain temperature increases of approximately 0.2°C were found.
While pressure sensor inaccuracy, particularly at time of implant, likely occurs as
a result of the fiber optic’s thermal coefficient, there are other possible factors
that may explain post-implant drift as well. Degradations resulting from
mechanical drift mechanisms of the optical diaphragm material, readout
electronics, and the systems interconnects may each further contribute to drift
over time. For sufficient sensitivity, the optical diaphragm must be very thin.
However, pressure deflections may often be larger than the thickness of the
material itself. While small deflections can be predicted linearly as with a normal
round circular plate [57], large deflections quickly turn non-linear [58] and can
extend into plasticity for the material. Once the deflections become plastic,
distortion effects occur where deformity can result in hysteresis and therefore
drift. Additionally, atmospheric pressure changes over the course of in-vivo
measurements have also been suggested as possible drift factors in the Camino
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Figure 5 – Thermal map of primate brain for two frontal sections (14.3 and 0.3).
(Source: The American Journal of Physiology, Hayward and Baker, 1968)
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sensor system, which are likely given its measurements are relative to a single
absolute reference source [59].
Direct Microstrain Measurement
In contrast to the direct fiber optic intraventricular or parenchymal probe reviews,
microstrain based sensors (i.e. piezoresistive pressure sensors) have received
relatively positive appraisals within the literature. Koskinen performed a
prospective study using the Codman Microsensor System (i.e. microstrain
sensor) with 128 patients whereby zero drift was measured upon explantation [5].
The study additionally performed 469 measurements on 22 patients that also
simultaneously used an intraventricular manometer for comparison. Results
were shown for the 22 patients to have an average ICP of 249±4 mm H2O
measured intraventricularly. The microstrain based device produced an average
of 258±3 mm H2O over the range of patient ICP. The overall mean drift across
the span of 7.2 ± 0.4 days was reported at 12 mm H2O (i.e. 1.67 mm H2O per
day) with bounds less than ±27 mm H2O in 79% of the devices. Koskinen
reported the findings from a clinical point of view as acceptable and that the drift
was low. A separate study of 88 patient cases utilizing the Codman Microsensor
System in two separate neurointensive care units also found a mean drift of ±27
mm H2O over a mean monitoring time of 108 hours [60]. An additional study
further confirmed similar performance in 60 cases using the Codman ICP monitor
whereby 43% of the cases demonstrated essentially zero drift while another 40%
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was within ±14 mm H2O. Maximum drift in all cases was reported to be 41 mm
H2O [61].
Spiegelberg also produces brain pressure monitors based on strain gauge
technology, but with a different approach allowing in-vivo recalibration. The
Spiegelberg monitor utilizes a sealed disposable air-pouch catheter transducer
which is semi-inflated by an accurately calibrated air pump [62]. The air pouch
catheter may be placed intraventricularly or within the parenchyma and further
provides simultaneous CSF drainage via a separate yet integrated lumen. The
resulting internal air pouch pressure is measured against the pump pressure to
deduce ICP. The advantage is two-fold: 1.) the pressure sensor remains ex-vivo,
whereby it can be recalibrated without need to remove the catheter, and 2.) the
system can optionally facilitate brain compliance measurements by further
displacing a small portion of brain volume (<0.1 ml) while another sensor
measures the ensuing rise in ICP. Drifts for the Spiegelberg brain pressure
monitor have been shown to be ±41 mm H2O over 28 days [63].
Another ICP monitor also employing strain gauge technology is the
LiquoGuard®7 manufactured by Möller Medical, introduced in 2011 following the
original LiquoGuard. The LiquoGuard7 is similar to Spiegelberg’s ICP monitor,
allowing for simultaneous ICP measurement while draining CSF. However, the
LiquoGuard7 is unique in that it regulates drainage via a closed-loop control
system comprising ICP measurement feedback to maintain a desired pressure
setpoint within the brain [64]. In this way, the system relieves intracranial
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hypertension by controlling the drainage of CSF electronically, not by gravity
alone. The benefit of this feature over other external ventricular drainage (EVD)
systems is that there is no need to level a burette to control CSF pressure and
flow. Therefore, patient ambulation is less restricted. For reliability and safety,
the monitor incorporates redundant systems for sensing pressure utilizing two
separate and independent strain gauge sensors each with independent
processing circuits. The sensors are integrated into the CSF drainage lumen and
attached to the patient at the level of the Foramen of Monro [65]. Optionally, the
control system may be simultaneously connected to a separate ICP monitoring
system for the measurement of ICP under conditions such as slit ventricles. The
system modulates CSF drainage, based on pressure sensor feedback, by
mechanically constricting its CSF drainage lumen using a pinch valve. CSF flow
is gravitationally driven by the pressure difference between that of the ICP and a
burette, or drip chamber, located at an elevation set lower than a patient’s
ventricles [66]. However, in a regulatory disclosure of the device, a peristaltic
pump is described as being used when ICP exceeds a preset threshold [67].
Drift of the device is largely unreported although the manufacturer indicates the
device drifts less than 14 mm H2O under long-term testing.
Samaun et. al. [68] described some of the early work of silicon microstrain
sensing for biomedical instrumentation, in particular for intravascular cardiac
measurements. In their work they developed a thin silicon pressure diaphragm
for the measurement of low stress with orthogonally oriented p-type implanted
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piezoresistors. They go on to describe proper orientation for achieving
magnification of stress measurement through the use of a bridge network in
which two resistors decrease resistance upon induced strain while the other two
likewise increase. Properties of pressure detection with diaphragm mechanics
were also thoroughly described in which sensitivity increases by the square of
the ratio of the diameter to the diaphragm’s thickness. Additionally, linear
regions of operation were described to be limited to about 40% deflection
compared to the thickness. The researchers fabricated two piezoresistive
sensors in which a sensitivity of 83 µV/Vsupply/mmHg and 14 µV/Vsupply/mmHg
was achieved for diaphragm diameters of 1.2 and 0.5mm, respectively. After
calibration and temperature compensation their work resulted in pressure
sensors accurate to within 1 mmHg (13.6 mm H2O) and with a range of up to 150
mmHg (2,039 mm H2O). However, Samaun described drift issues with the silicon
microstrain sensing technique where temperature sensitivity of the diffused
piezoresistors was significant, but correctable. Additionally, Samaun found that
mechanical creep due to different expansion coefficients between the sensor and
mounting also contributed to drift over time and could very well dominate longterm drift.
Yurish [69] reviewed a variety of techniques concerning the readout of piezoresistive strain sensors. His review covered high end analog to digital
approaches and more cost sensitive microcontroller readout techniques.
However, he cautioned against clock trigger noise affecting readout with direct
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microcontroller techniques. Yurish provided an overview of modern-day
application specific integrated circuits (ASIC) available through commercial
means for the dedicated readout of microstrain sensors. Most of the ASICs
provided digital outputs via either I2C or SPI. He cited Smartec as offering a
pulse width modulated (PWM) output, but that it was only compatible with
resistive bridges ranging from 10Ω to 250Ω. Yurish noted that often, for remote
sensing applications, the sensor’s signal is converted to a frequency or duty
cycle signal. Yurish’s work consisted of developing a variable frequency output,
representative of the entire bridge resistance, with a variable duty cycle
representative of the bridge’s unbalance for a very wide variety of bridge
parameters. In this way, Yurish approached the problem of bridge temperature
variation by encoding the common mode effects into the circuit’s frequency
output and the bridge’s strain signal into the duty cycle.
Similar to Yurish, Crescini et. al. [70] also developed a readout circuit for a piezoresistive pressure sensor, but with the intentions of high temperature
applications. Crescini’s readout circuit measured the overall bridge resistance of
the sensor and encoded this into an output square-wave carrier frequency. The
duty cycle of the square wave depended upon the imbalance within the bridge,
representing the incident pressure. Crescini, in agreement with Yurish, explained
the advantage of such an approach in that the electronics could be safely located
away from the sensor with a minimal degradation in accuracy. Important to
Crescini’s application was that the implied temperature was encoded by the
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carrier frequency. Crescini claimed the sensor’s output transmission was highly
noise-immune and could be directly interfaced to a microcontroller for A/D
conversion.
Other Direct Techniques and Modern Approaches
Capacitive based sensors are not currently prevalent within clinical practice for
ICP measurement, but nevertheless have been attempted in the past and are a
topic of study within the bioMEMS area of research. George, et. al. recently
described fabrication of a micro-electro-mechanical (MEM) based capacitive
catheter sensor for ICP measurement [71]. In this type of sensor, metal upon a
silicon die was used to form a variable capacitor whereby one electrode was
fixed and a second was moveable in response to fluid pressure. George
reported typical sensitivities for such sensors on the order of tens to hundreds of
atto Farads per millimeter of mercury (i.e. 13.6 mm H2O) with a fabrication
tolerance of only about ±5%.

George went on to summarize that not only was

the sensitivity of their device low and not well controlled, but that a large offset
was present as well. It is likely that George’s results are indicative of why such
sensors are not as prevalent within the industry as strain and optical
interferometry methods. Stanford researchers Chen et. al. reported improved
sensitivity gains utilizing a MEMS structure configured in a distributed resonant
tank circuit fabricated from styrene butadiene styrene (SBS) elastomer [72]. The
sensor was remarkably small at only 1 x 1 x 0.1 millimeters. The team overcame
traditional operating frequency limits and deployed the sensor in-vivo in a rat.
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One issue, however, was drift in capacitance values that resulted from
measurement cycling. Additionally, there was drift due to the slow diffusion of
water vapor through the polyimide substrate and adhesives, which caused a
gradual decrease of the sensor’s resonant frequency. The diffusion of water into
the material likely altered the material’s permittivity causing an increase in the
effective permittivity between substrate layers. This drift mechanism has also
been described by others, including most recently by Behfar [73]. Capacitive
based biopressure sensors for low-pressure measurements (i.e. <100 mm H2O)
have additionally been subject to drift due to small amounts of biomatter
accumulation, particularly for sensitivities less than a femto-Farad per millimeter
of mercury.
One successful deployment of capacitive based pressure sensing, however, is in
the case of the CardioMEMSTM EndoSureTM sensor [74]. This sensor represents
the latest commercialization work for wireless sensing of cardiovascular pressure
monitoring, which incorporates a MEMs based capacitive pressure cell. The
sensor is installed with a stent graft during endovascular repair and is entirely
passive, consisting only of an inductor, capacitor, and a diode. The sensor
operates via ex-vivo wireless power stimulation, which results in a resonant
frequency proportional to pressure induced capacitance. The resonant
frequency is detected by an external radio receiver, which typically results in a
sensitivity of 10 kHz per millimeter of mercury (i.e. 13.6 mm H2O) [75]. Allen also
reports that typical frequencies for such a sensor operates around 30 to 40 MHz
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and with Q-factors of approximately 50. He indicated ex-vivo readout distances
of approximately eight inches. While the EndoSure device provides a novel
means of cardiovascular pressure interrogation, the pressures levels associated
with blood pressure only begin near the maximum of those necessary for ICP.

Indirect ICP Measurement
Indirect methods of assessing ICP are based upon measuring related
physiological parameters that correlate to true ICP. Indirect techniques may be
either invasive or non-invasive. This section of the literature review surveys
invasive means for indirect ICP assessment while the next section surveys noninvasive indirect methods.
The oldest known method of ICP measurement utilizes lumbar puncture and a
manometer while a patient carefully lies in a lateral recumbent position [76].
Commonly, the opening pressure (i.e. initial pressure) and closing pressure (i.e.
after drainage of CSF) are used as potential clinical indicators of intracranial
hypertension. This technique works for communicating CSF (i.e. without
obstruction) and provides an indirect measurement of ICP, albeit with significant
disadvantages and inaccuracies [17] especially for patients under general
anesthesia. Czonsnka and Pickard [19] reported misleading ICP for instant fluid
column measurements and suggested that such pressures should be averaged
over at least 30 minutes or more preferably overnight.
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Intraparenchymal sensing is likely the most contemporary prevalent method of
overall ICP sensing [18]. Hawthorne described it as being the preferred
technique of many centers even over intraventricular measurement [49]. Being
indirect, the method utilizes a solid-state pressure sensor (e.g. fiber optic or
microstrain) placed through a burr hole into the brain’s white matter within the
non-dominant frontal hemisphere. Wiegand describes intraparenchymal
sensors as being the most reliable instrumentation available, easy to place, and
with few infections (1 – 2%). The same was supported by Luerssen [50]. He
describes their use in Oxford, where surgeons have placed 583 devices, as of
the time of publication, in which they (re)zero the devices daily to atmospheric
pressure. He indicated the intraparenchymal microstrain sensor (i.e. the
Codman MicroSensor) was the device of choice in both emergency and elective
cases at Oxford. Several studies have shown microstrain parenchymal sensing
to be as accurate as intraventricular measurement [5, 77].
Other indirect invasive approaches exist, as illustrated in Figure 6.
Measurements by epidural, subdural, or subarachnoidal access provide
pressures which may be associated with ICP. Subdural and subarachnoid
measurements are quite rare in modern clinical approaches [17]. They require
the use of bolts for anchoring to the skull with an open saline-filled lumen, placed
just under the dura, connected to a transducer. Weigand indicates they are less
prone to infection than direct measurements (e.g. ventriculostomy), but may be
compromised upon brain swelling blocking the lumen. Roboel cited concerns for
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intercompartmental pressure gradients and focal ICP elevations as a reason to
choose intraparenchymal or intraventricular measurements instead [48].
With respect to epidural measurements for assessing ICP, pressure may be
measured in between the skull and dura with a sensor facing the brain. Zhang
described the benefits of such measurement as a lower probability for infection,
hemorrhages, and seizures compared to direct methods [18]. Further, in the
case of an epidural measurement, the dura may be left uncompromised, avoiding
the risk of a CSF leak. However, there are concerns with the dura diminishing
true ICP translation and overall the method’s accuracy has been deemed not
support routine clinical use by some clinicians [17, 18].

Figure 6 - Illustration of various ICP measurement techniques.
(Source: Harary, Dolmans, & Gormley)
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Non-Invasive ICP Assessment
All non-invasive approaches to ICP assessment are indirect, meaning they use
physiologically related measurements that may be correlated, or proportional to
actual ICP. Sonography techniques allow for one such non-invasive assessment
by measuring a patient’s optic nerve sheath diameter. The optic nerve sheath is
an extension of the dura mater, which is the tough outermost membrane
enveloping the brain and spinal cord. The perioptic nerve’s fluid is generally in
communication with CSF, hence providing an avenue for ICP evaluation [78].
Studies [79] have shown that the nerve diameter, as assessed by transorbital
sonography in the transverse plane, 3 mm posterior to the papilla, is linearly
related to ICP and can be indicative of hypertension. For patients under normal
CSF pressures, the optic nerve sheath was found to have a mean diameter of 3
mm. However, for those patients of increased ICP, the optic nerve sheath
diameter was found to average 5 to 6 mm. While this non-invasive technique
offers a quick and inexpensive method of qualitatively indicating elevated ICP,
the deployment and efficacy of the method may require expert interpretation [17].
Of recent development, and sparsely reviewed in the literature, is the potential for
non-invasive ICP assessment by ultrasound measurement of the ophthalmic
artery (OA). The OA stems from the internal carotid artery within the cranium,
transporting blood along the optic nerve to the orbit. The OA is subject to ICP
within the cranium, but not in the orbit where pressure is equal to atmospheric.
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The diameter of the OA inside the cranium is smaller than within the eye due to
ICP. Consequently, blood flow velocity is higher intracranially than within the
orbit. Vittamed, founded in 2013 and associated with U.S. based Boston
Neurosciences, is currently developing instrumentation for measuring the OA
blood flow velocity within the cranium and within the orbit using a dual-depth
high-resolution transcranial Doppler insonation [80]. The approach necessitates
extracranial orbit compression to equate blood flow velocities in both locations.
The equilibrium pressure is then interpreted as ICP. Ragauskas reported results
from a study of 62 patients where simultaneous recordings of OA based noninvasive ICP measurements were compared to direct measured ventricular
pressure [81]. Results showed low systemic error of 1.6 mm H2O with a
precision of 30 mm H2O. The authors suggested the OA method did not need
calibration. However, in a 2016 review by Robba et. al. the clinical practicality of
the new method was questioned due to the uncertainty in locating the intracranial
and extracranial segments of the ophthalmic artery [20]. Robba suggested that
even if clinicians were to overcome doubts of being able to find the ophthalmic
artery, then the technique would require highly skilled transcranial Doppler
specialist with fine anatomical knowledge.
Other non-invasive approaches to ICP have been proposed and researched
within the literature. For instance, the delay of visually evoked N2 electrical
potentials, as measured upon a patient’s scalp, have been correlated to rises in
ICP [82]. The challenge, however, is with the practicality of the clinical setup for
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the measurement and interpretation of the delays, which may require
neurophysiological expertise. Neonatal fontanelle compression is yet another
ultrasound method whereby an infant’s “soft spot” is compressed during Doppler
sonography to examine the hemodynamic response. While qualitative in nature,
the technique provides a method of assessing progressive or persistent
elevations in ICP for neonates with hydrocephalus. Several literature reviews
have categorized numerous non-invasive approaches into five categories
consisting of fluid dynamics, ophthalmic, otic, electrophysiologic, and
miscellaneous [18, 78]. Table 1 outlines the various techniques which have
been researched and reviewed throughout the literature.
Overall, with respect to the most current non-invasive approaches to ICP, all
authors reviewed concluded that ventricular catherization remains the gold
standard. Furthermore, there was consensus that non-invasive ICP
assessments were presently only qualitative and insufficiently accurate enough
for routine clinical use to provide an alternative to invasive approaches [17, 18,
20, 48]. Nonetheless, Wiegand attributed non-invasive assessments as clinical
signs, complimentary to diagnosis, such as clinical history, physical examination,
and radiological methods for the assessment of elevated ICP. Altogether, noninvasive solutions are desperately needed and therefore continue to be the topic
of much research.
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Table 1 – Non-Invasive ICP Approaches

Non-Invasive ICP Method Category

Measurement Technique
Magnetic resonance imaging (MRI);
transcranial doppler ultrasonography

Fluid Dynamics

(TCD); cerebral blood flow velocity
(CBFV); near-infrared spectroscopy
(NIRS); transcranial time-of-flight;
Spontaneous venous pulsations (SVPs);
venous ophthalmodynamometry (ODM);

Ophthalmic

optical coherence tomography (OCT) of
retina; optic nerve sheath diameter
(ONSD); pupillometry;
Tympanic membrane displacement
(TMD); otoacoustic emissions

Otic
(OAE)/acoustic measure analysis;
transcranial acoustic (TCA) signals;
Visual-evoked potentials (VEP);
Electrophysiologic
electroencephalogram (EEG);
Skull vibrations; brain tissue resonance;
Miscellaneous
jugular vein analysis;
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ICP Telemetric Approaches
Transcutaneous communication with human implantable devices have been
reported in the art comprising optical, inductive, or high frequency radio
techniques as reviewed by Townsend [83]. An ICP transponder concept
essentially encompasses wireless communications, and optionally power, to an
implantable self-contained pressure sensor, which for ICP, could be deployed for
either direct or indirect measurement. It was first proposed by R. Stuart MacKay
in 1965 with initial prototypes developed by Atkinson et. al. in 1967 for one of the
most troublesome diseases, hydrocephalus [84, 85]. Atkinson developed an
entirely passive transponder, shown in Figure 7, consisting of an inductor and
capacitive based absolute pressure sensor (i.e. LC tank circuit) that operated
around 70 MHz.
The transponder’s frequency would vary with ventricular pressure as one side of
the capacitor consisted of a stainless-steel diaphragm 8mm in diameter. The
Atkinson device was implanted in a 2-month-old infant. They described hesitation
about deploying the sensor in either the epidural or subdural space as ICP may
be dampened by scar tissue. Rather, they coupled the sensor to a ventricular
catheter. The results were successful in that they detected changes in
ventricular pressure, including variations with the patient’s respiration, but not
arterial pressure pulses. The system was reported to have 5 mm H2O of
telemetric noise. Atkinson reported of several problems including drift arising
from stray capacitance, which reduced the sensitivity of the device, thought to be
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Figure 7 – Transponder described by Atkinson et. al. [84]
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from water absorption. Furthermore, the absolute pressure sensor was subject
to atmospheric pressure changes in which the authors described the “transensor”
as an aneroid barometer or altimeter. They additionally cited diaphragm
materials as presenting an issue. Nevertheless, development, testing,
implantation, and operation of the device was a landmark for telemetric ICP
sensing.
Differential pressure sensors were deployed during the 1970’s as an improved
attempt to circumvent atmospheric pressure changes [86]. Cosman developed a
differential sensor for measuring subdural pressure, which would potentially
negate atmospheric pressure changes. The sensor was designed to provide
accurate ICP by comparing to an external pressure palpated to the scalp above
the sensor [87]. The transponder communicated by radio telemetry, similar to
Atkinson, being based on an LC tank circuit. Cosman’s approach would
simultaneously detect the zero-point of the sensor corresponding to a balance of
pressures across it (i.e. ICP – pressure by palpation). This device was
commercialized despite its 24% failure rate within the first week of implantation
[44].
In 1988 a ten-year follow-up on the performance of an epidural telemetric sensor
was reported by Gucer et. al [88]. Similar to prior work, it was also an LC tank
circuit whereby a capacitor was the pressure sensitive element. The device was
implanted into 127 patients. 13 of the patients retained the sensor for between 4
to 9 years. Gucer and team evaluated the sensor for accuracy, longevity, safety,
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and stability. The sensor was found safe and enduring without even one
infection. Sensitivity was sufficient enough to pick up ICP waveforms. However,
drift was drastically unacceptable at 1.0 ±0.2 mm H2O per day. The drift was
responsible for patients telemetrically measuring 2,290 mm H2O, when they
actually had normal ICP. Biofluid intrusion was also an issue due to the
packaging and diagraph fatigue.
Despite numerous efforts throughout the past fifty years, no telemetric
biopressure sensor device has attained the commercial success like that of the
CardioMEMS for arterial blood pressure. The transponder is altogether similar to
that proposed by Atkinson, Cosman, and Gucer. It is a battery-less device,
excited by ex-vivo radio frequency (RF) energy in which the transponder
responds with a resonant frequency based on an LC tank circuit. Pressure is
proportional to its capacitive sensor in parallel with an inductor. The device is
entirely encapsulated in glass, minimizing frequently reported drift mechanisms
associated with biofluid intrusion in capacitive sensors [89]. Power transfer for
the device likely lies around 300 µW with DeHennis and Wise reporting inductive
power consumption for a similar device at 340 µW and Brancato the same at 300
µW [90, 91]. The sensor is intended for at least a 3-year implant life, but drift
data has not been made public or published, except for qualitative reports
indicating it is low and acceptable for arterial pressure use [89]. However, such
pressure ranges are approximately an order of magnitude larger than that
necessary for ICP measurement.
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Raumedic Neurovent-P-tel
Modern developments in implantable telemetric ICP sensors include two recently
commercialized European models: the Raumedic NEUROVENT-P-tel and the
Miethke Sensor Reservoir [92, 93]. Both models are reportedly based on
microstrain transducers. The Raumedic device, shown in Figure 8, is a standalone remote intraparenchymal sensor, completely passive, with first clinical use
in 2010. The device is currently approved in Europe for use up to 90-days. It
consists of three main system components: the transponder, the ex-vivo active
antenna unit, and the storage monitor. Pressure measurements can be taken at
frequencies of 1 or 5 Hertz. Specifications indicate an operable pressure range
of -20 to +400 mm Hg with an atmospheric limit of 1,500 mm Hg. Accuracy is
specified at ±2 mm Hg with a sensitivity of 1 mm Hg [38].
Antes, et. al. with the Saarland University Medical Center in Homburg, Germany,
reported use with the Neurovent P-tel device in 247 patients [37]. He describes
the device as having a 3 cm long polyurethane sensor catheter with a diameter of
1.67 mm for intraparenchymal placement, which Welschehold indicates is
silicone coated. Further he details that the sensor housing is made of ceramic at
a diameter of 3.15 cm and a height of 4.3 mm. The P-tel device is inductively
powered and provides data transfer via load modulation.
Out of 247 patients, only seven technical problems occurred with one being due
to trauma. The P-tel had a mean time of implantation of 46.9 days with a range
between 3 and 90 days. Antes reported the system was very easy to use and
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Figure 8 - Raumedic NEUROVENT-P-tel [38]
(Source: Welschehold, Schmalhausen, et. al.)
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staff could be instructed within only a few minutes for operation. Disadvantages
were noted related to incorrect alarm settings or insufficient fixation of the
sensitive antenna, interrupting ongoing measurements, sometimes for days. He
also described that the readout module’s software was a weak point, lacking the
ability to provide simple mathematical or statistical measurements (e.g. min, max,
average, etc.).
Antes cited a negligible zero-drift of about ±2.5 mm Hg but neglected to describe
the interval or whether the zero-drift was measured or taken from a specification.
Stehlin cited Raumedic as specifying a drift of ±2 mm Hg per year with the ability
of the Neurovent-P-tel to provide reliable pressure data up to 18 months in-vivo,
albeit regulatory limited to 90 days [44]. However, Welschehold et. al. in first use
of the device cited a drift of ±2 mm Hg per 29 days [38]. Reports for Raumedic’s
similar microstrain tethered monitor has measured a drift of 0.6 mm Hg after five
days implantation into the parenchyma [49] and would more closely coincide with
that reported by Welschehold. Lastly, Antes described that a major shortcoming
of the device was the limited 90-day implant period whereby a second surgical
procedure was required to remove the probe. He indicated the second surgical
operation often deterred many potential candidates.
Meithke Sensor Reservoir
In 2015, Meithke similarly introduced a telemetric ICP sensor, shown in Figure 9,
which integrates into a shunt’s Rickham reservoir, named Sensor Reservoir.
Unlike the Raumedic counterpart, the Miethke device communicates directly with
43

Figure 9 - The Miethke SENSOR RESERVOIR
(Source: Christoph Miethke GmbH & Co. KG)
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CSF from the ventricle. It consists of three main system components: the
passive sensor implant, an ex-vivo active antenna/exciter unit, and a tethered
handheld reader/display unit which can store pressure data on an SD card. The
manufacturer claims, that for the first time ever, the system is capable of
assessing shunt function. Miethke describes uses of the sensor encompassing
non-invasive ICP detection, localization, and evaluation of occlusion in a shunt as
well as shunt mechanical malfunctions [94]. The sensor measures 23.8 mm in
diameter and 7.6 mm in height.
Again, a team of neurosurgeons at the Saarland University Medical Center
evaluated the implantable sensor in 25 patients over the course of a year. Antes
describes the sensor being housed in a polyether ether ketone housing with a
silicone dome, similar to a shunt reservoir [42]. However, he states that unlike a
conventional reservoir, the device also contains a titanium-covered measuring
cell for noninvasive transcutaneous ICP measurement. True to its name, the
device can function as a reservoir and be tapped percutaneously for drug
delivery or CSF withdrawal. Contrary to other reports citing microstrain sensing,
including the latest publication in 2018 from Harary, Antes reports that the sensor
unit contains an application specific integrated circuit (ASIC) with 64 capacitive
sensors [43]. CSF envelops the measuring cell and pressure is directly
transmitted directly through the housing via a 12.0 μm titanium plate. ICP values
can be read out at a rate of 44 samples per second (i.e. Hertz). Antes indicates
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the implantation period of the Sensor Reservoir is unlimited and explanation is
unnecessary with respect to regulations.
Antes and team selectively deployed the Sensor Reservoir into 25 patients
between December 2015 and November 2016 who were suffering from
headaches. They categorized measurements as normal ICP, underdrainage,
over-drainage, and imbalanced CSF drainage. A total of 183 telemetric
measurements were taken during the period, which resulted in 85 valve
adjustments. Antes reported that obtaining ICP measurements was quick. Such
measurements and adjustments were reported to have positive clinical
improvements in 18 of the 25 patients. Interestingly, Antes reported that contrary
to expectations, ICP was not well correlated with shunt valve settings. Antes
indicated this may be due to two possible reasons: 1.) short-term measurements
may not represent average ICP, and 2.) valve setups utilizing both a differential
pressure valve and a gravitational valve in series may influence drainage to an
incalculable degree.
Shortcomings of the device were reported as the thickness at 8 mm, especially
for patients with thin skin. Antes also described the desire to take continuous
measurements over a one- to two-day periods to detect certain pressure leaks,
pulse pressure, and pathological slow waves. He further cited that the ex-vivo
antenna was too large and heavy to facilitate fixation to a patient’s head. Out of
25 patients, two devices provided improbable ICP measurements. One patient
presented with slit ventricles and no sufficient ICP pulse signal was detected,
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with ICP very negative. The other patient’s device, placed into dilated ventricles,
showed disproportionately high ICP values soon after insertion. No comparisons
to true ICP, measured by ventriculostomy, were presented. As such, there was
no report on measurement drift, but Antes did state he did not believe the device
could remain accurate beyond five years.

Research Gap and Limitations
As described in the Challenges of Intracranial Pressure Monitoring section,
pressure sensor accuracy, especially in terms of drift, remains an unsolved and
prominent issue. As a result, standard clinical practice necessitates the use of
bedside tethered equipment which must be frequently recalibrated. Infection
rates associated with tethered ICP monitors range up to 10% for gold standard
ventriculostomy measurements. Avenues for eliminating tethered devices, and
thereby reducing infection rates which increase over time, are restricted due to
drift over the long-term (i.e. << months). Clearly shown within the same
Challenges section is the immense need, however, for such telemetric pressure
sensing devices.
Yu, in his review of the challenges and state of the field for chronically
implantable pressure sensors, stated that sensors must possess a stable and
consistent response over their lifetime [46] to be effective, of course. However,
to date, the state of technology for biopressure sensing has not achieved such a
response to enable the very low-pressure measurements of ICP over a several
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year lifetime of implantation. Yu cited material aging and mechanical fatigue as
primary contributors to both baseline (i.e. zero-drift or offset drift) and sensitivity
(i.e. gain) shifts.
Drift mechanisms have been researched and reported throughout the various
sensors developed and cited herein encompassing atmospheric pressure or
altitude changes, electrolytic biofluid intrusion, temperature changes, gas leaks,
static discharge effects, among others beyond those described by Yu. Efforts to
mitigate these effects include Cosman’s work in the 1970s utilizing differential
pressure sensors, including the application of a known external pressure to
calibrate the subcutaneous sensor. Additionally, development by Spiegelberg of
their tethered monitor employing an air chamber transducer facilitates
recalibration of external pressure sensors without removal of a
catheter/transducer. However, research and development to date has not
revealed any methods to mitigate drift to a clinically acceptable level, either by
reduction or calibration, to enable long-term implantation of a telemetric ICP
biopressure transponder. Both drift reduction and non-invasive in-vivo
calibration for clinically acceptable ICP measurement is the pursuit of this
research.
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CHAPTER THREE
MATERIALS AND METHODS
Overview
This research investigates the current limiting factors preventing long-term
implantable ICP measurement. Recognizing drift as the primary inhibitor, this
work endeavors to minimize inherent pressure sensor drift and to mitigate both
offset and gain shifts via a novel in-vivo calibration system. Achieving such an
advancement could possibly facilitate the world’s first ever accurate long-term
(i.e. >>1 year) implantable ICP monitor. Such a sensor system with this
capability would allow for post-implant non-invasive ICP monitoring to provide
early warning or confirmation of dangerously elevated ICP levels. Furthermore,
the capability to accurately measure ICP long-term would facilitate optimization of
hydrocephalus shunt valves or even automated closed-loop systems.
A review of the literature, assessing prior clinical research, was reported within
the Literature Review for assessing the physiological approaches and variables
of ICP measurement. Additionally, a survey of sensing technology for ICP
measurement was conducted and reported. Within this chapter, requirements
and research objectives are established for building upon prior research for
enabling long-term ICP sensing. Design considerations for a new novel
biosensor are described in the following sections of the Approach. Finally,
methods for simulation and laboratory verification of a new novel prototype
49

sensor are outlined.
Methods undertaken by this work include:
1. A review of prior clinical research assessing the physiological approaches
and variables to ICP measurement.
2. A survey of sensing technology, including shortcomings or sufficiency for
ICP measurement.
3. Establishment of requirements and research objectives for a long-term
ICP biosensor.
4. Design of a novel custom sensing device and methodology for calibrated
ICP measurement.
5. Simulation of key design characteristics and uncertainties.
6. Laboratory evaluation of selected sensing die technology for potential
application in ICP sensing.
7. Development of a prototype sensor with laboratory verification of key
performance metrics.

Requirements
General requirements for the sensor include the use of biocompatible material
interfaces, geometrically acceptable for implantation. The sensor must further
support non-invasive readout and ultimately provide clinically acceptable
resolution and accuracy. Overall, the biopressure sensor transponder (i.e. the
entire sensing and telecommunicating implant) should provide reliable long-term
operation, durability and, preferably, battery-less operation. The sensor may
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preferably utilize transcutaneous energy to eliminate the need for a transponder
battery, which may present hazardous toxic materials, or necessitate
replacement via revision surgery. The focus of this work is upon minimizing or
mitigating sensor drift. Specific requirements for the sensor follow within this
section.
The Association for Advancement of Medical Instrumentation (AAMI) provides a
standard for intracranial pressure monitoring devices, with its latest revision in
2015 [95]. The scope of the standard encompasses percutaneous fluid and
electrically coupled sensing devices, common in today’s neuro-ICU wards,
patient interfaces including sensor contact and display devices, and fully
implantable type devices. Its purpose is to provide labeling, safety, performance
requirements, and test methods for assuring the safety and effectiveness of ICP
monitoring devices. The standard indicates its concepts are to be considered
flexible and dynamic as advances are made in ICP monitoring technology.
Relevant to the scope of this work, intended for initial research, development,
and evaluation, the standard’s recommendation for pressure range, accuracy,
and zero-drift will be considered.
As previously revealed in a survey of the literature, Kimelberg and Ravi showed
normal ICP to range from 0 to 136 mm H2O in the supine position, which can also
become negative in the upright position according to Sotelo. For shunted
patients, negative pressures up to -440 mm H2O have been described due to
siphoning effects, which can result in CSF over drainage [96]. Koskinen showed
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pathological ICP to average 249 mm H2O with Lundberg showing extreme ICP’s
of 500 mm H2O and beyond, particularly for head trauma patients. The AAMI
standard requires monitoring of 0 to 1,400 mm H2O. However, given the
standard’s broad scope and rationale, which includes bedside critical care acute
monitoring for the critically ill, the upper end range of 1,400 mm H2O may be
excessive for long-term monitoring of hydrocephalus patients. Such long-term
monitoring, as sought herein, is intended to provide ongoing ICP measurements
to verify shunt functioning, optimization, and early warning levels prior to acute
levels of intracranial hypertension. As reported by Lundberg, pressures beyond
500 mm H2O are considered severe. Young’s research additionally showed that
levels of 1,000 mm H2O or greater typically resulted in brain herniation and death
within 24 hours. While pressure monitoring of levels beyond 1,000 mm H2O
would be desirably broad, such levels are associated with head trauma which
necessitate acute care intervention and pressure monitoring. Unnecessarily
increasing the pressure sensing range for a long-term implantable monitor would
reduce sensitivity and accuracy due to the pressure diaphragm’s configuration.
Instead, given the variety of everyday patient positions, versus an acute care
setting, it is important for long-term monitoring to allow for negative pressures
range rather than an extended positive pressure only (i.e. 0 to 1,400). Therefore,
for this work, a pressure range of -500 mm H2O to +500 mm H2O will be adopted.
Insight into clinically acceptable sensor resolution can be gained by examining
hydrocephalus shunt valve resolutions. Lollis et. al. performed a review of the
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most prevalent programmable hydrocephalus valves on the market in 2010
consisting of the Codman® Hakim® Programmable valve, the Medtronic® Strata®
valve, and the Sophysa® Polaris® SPV valve [97]. The authors additionally
reported on the Aesculap® ProGAV®. However, this is an anti-siphon auxiliary
valve used only in-line with a primary valve. Out of all the valves Lollis reviewed,
the Hakim Programmable valve had the best resolution of 10 mm H2O. Upon
further examining manufacturers’ present offerings, as of the time of writing, no
valve currently marketed provided a higher setting resolution than the Hakim
Programmable valve. Medtronic’s valves provide a range of pressure-flow
characteristics in which the Delta programmable valve’s Instructions for Use
(IFU) indicates a setting tolerance range of ±40 mm H2O [98]. Maximum
pressure range encompassing all the primary valves examined by Lollis was 200
mm H2O, consistent with normal pressure levels reported by Drake and Sotelo.
Therefore, given the highest resolution valve in clinical use resolves to 10 mm
H2O, as of the time of writing, and given this would represent 1% of the sensor’s
overall span (i.e. ±500 mm H2O), 10 mm H2O will be selected as the minimum
clinically acceptable resolution for the pressure sensor system researched
herein.
In assessing the accuracy necessary for the sensor, it has been shown that
adjustment of a valve’s setting by only 20 mm H2O or less can have clinical
impact upon pediatric patients [99]. Therefore, to not introduce uncertainty
beyond half this range, an accuracy of ±5 mm H2O will be set as an objective for
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the system. Likewise, the sensor’s precision objective will be targeted for ±5 mm
H2O so as to not cumulatively extend beyond the 20 mm H2O range for clinical
effect. Combined, the sensor’s accuracy and precision objectives of ±5 mm H2O
each results in a total possible error of ±10 mm H2O, or a 20 mm H2O range,
which will be adopted over the span found by Lollis of 200 mm H2O. This is
within the AAMI standard’s requirement of ±20 mm H2O (40 mm H2O range) over
a 0 to 200 mm H2O range. Thereafter, the standard calls for ±10% maximum
error and will be adopted for this scope of work as well.
With respect to the sensor’s pressure drift, service life of the implantable sensor
comes into question. Prospective studies have shown the failure rate of CSF
shunts is approximately 50% by year two and between 70% to 88% by year ten
[31, 32, 33, 34]. Therefore, to serve the majority of patients with a diagnostic
device complementing shunt treatment for both shunt optimization and as a
diagnostic for shunt failure, the sensor will be planned for an expected 10-year
service life. The sensor serves two functions: First, pressure monitoring for valve
setting optimization, maintenance, and research; Secondly, as a non-invasive
indicator of shunt failure to distinguish alarming ICP values (e.g. >200 mm H2O)
prior to escalating and dangerous ICP levels. To distinguish alarming ICP, the
sensor error should be less than ±50 mm H2O such that a measurement of 250
mm H2O, for example, would confidently signal clinical intervention without
potentially posing a false alarm (i.e. 200 mm H2O or less where a valve’s setpoint
may be set). At the same time, a 250 mm H2O measurement would not
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erroneously allow drift error in excess of 300 mm H2O true pressure, well within
the range of clinical intervention and management. Therefore, over a 10-year
service life, the sensor must not encounter drift, on average, of more than 5 mm
H2O per year incrementally and successively over the service period (i.e. +50
mm H2O or -50 mm H2O), which cannot otherwise be corrected by sensor
calibration. This performance metric will be considered separate from the sensor
system’s accuracy at time of manufacture. Drift specifications with the AAMI
standard relate specifically to zero, or offset drift, and testing occurs over a
minimum of 10-days at 0 mm H2O. There is no specification within the standard
related to drift other than the accuracy cited.
Table 2 outlines the key requirements and research objectives developed as
goals for this work. The objectives are aimed at satisfying the key requirements,
in part, as related to the scope of the sensor research herein. Each objective is
keyed and will be cited within Chapter Four’s Results and Discussion.

Approach
Sensor Technology
Based on the literature review, among the various techniques and methods of
measuring ICP, there are two dominant transduction means that have clinically
demonstrated sufficient sensitivity for measuring the very low pressures of CSF.
Both methods are based upon diaphragm translation, including microstrain
sensing and fiber optic interferometry. Results from Koskinen and Olivecrona
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Table 2 – Key Requirements and Research Objectives Summary
Key Requirements for
Top Level
Requirements
Sensor Element(s)
R1.0 The sensor
R1.1 The sensor must
must provide
present a
biocompatible
biocompatible
interfaces.
silicon pressure
diaphragm and may
optionally include a
long-term
compatible parylene
coated membrane
or silicone gel
coupling for
pressure
transduction. Any
other direct
contacting
materials, such as
sealants and
adjoining enclosure,
must be
biocompatible.
R1.2 Surfaces must be
capable of being
cleaned and
undergo
sterilization.

Research Objectives
O1.1

Justification of
sensor to present a
bottom-side bulk
micromachined
monocrystalline die
surface for the
pressure
diaphragm to meet
biocompatibility.
Die must be
capable of bonding
to suitably hermetic
biocompatible
materials. Sensor
must withstand
sterilization
method(s).

O1.2

Device must be
capable of
sustaining a
compatible wash
and autoclaving,
ethylene oxide, or
gamma radiation
sterilization without
damage.
Surfaces must be
capable of
hermeticity to meet
the intended
service life of the
implant.

O1.3

→
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Table 2 (continued)
Top Level
Requirements
R2.0 The overall
sensor
transponder
must be
geometrically
acceptable
for
implantation.

Key Requirements for
Sensor Element(s)

Research Objectives
O2.1

→

R3.0 The sensor
must provide
clinically
acceptable
ICP
resolution
and
accuracy.

O3.1

→
O3.2

→
O3.3

→
O3.4

→
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The sensor's
transponder
components must
be capable of
being contained
within a typical
CSF reservoir's
volume (34 mm
diameter and
7.2mm height) for
suitable
implantation below
the scalp, yet
above the skull,
with pressure
communication
through a cranial
burr hole.
Sensor must
provide a pressure
range from -500
mm H2O to +500
mm H2O.
Sensor must
provide a 10 mm
H2O resolution, or
less, up to 200 mm
H2O and within a
10% maximum
beyond.
Sensor must
provide a
maximum accuracy
(or trueness) of ±5
mm H2O.
Sensor must
provide a
maximum precision
of ±5 mm H2O.

Table 2 (continued)
Top Level
Requirements

Key Requirements for
Sensor Element(s)

Research Objectives
O3.5

→

R4.0 The sensing
mechanism
must support
non-invasive
readout.

R4.1 The sensor and/or
supporting
electronics must
provide a
compatible
electrical signal for
non-invasive
transcutaneous
transmission.
R4.2 The sensor and
associated
transponder
electronics must not
exceed a power
consumption limit
necessary to
operate over a tenyear service life or
that exceeds a safe
level for
transcutaneous
powering.
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The sensor must
overall provide a
combined
maximum accuracy
(incl. precision) of
±10 mm H2O.over
a ±200 mm H2O
range and 10%
maximum beyond.
O4.1 Buffered sensor
output must be
capable of
providing a signal
within a 0 - 3.3 volt
range for
interfacing to the
Texas Instruments
CC2541 ADC and
Bluetooth LE
system-on-chip.
O4.2 The estimated
power consumption
of the sensor's
transponder must
be less than that
which can be
transcutaneously
transmitted safely
per IEEE Standard
for Safety Levels
with
Respect to Human
Exposure to Radio
Frequency
Electromagnetic
Fields, C95.1.

Table 2 (continued)

Top Level
Requirements

R5.0 The sensor
must support
a ten-year
service life.

Key Requirements for
Sensor Element(s)
R4.3 The sensor must be
capable of noninvasive postimplant calibration
(or otherwise
maintain acceptable
accuracy and
precision as
specified).
R5.1 Drift performance
must be sufficient
for indicating shunt
failure or for
distinguishing
dangerous ICP
values.
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Research Objectives
O4.3

The sensor must
be capable of gain
and offset
calibration to meet
the specified
accuracy.

O5.1

Expected drift over
the device's
intended service
life must be less
than ±50 mm H2O.

demonstrated that ICP microstrain sensing resulted in the lowest drift
measurements over time and temperature, notwithstanding the manometer,
compared to fiber optic and capacitive means. Distal fiber optic transduction
lacks temperature compensation methods, and when calibrated ex-vivo without
temperature-based zeroing, the technique easily results in thermally related
pressure shifts in-vivo. Capacitive based sensors for low pressure liquid media
sensing have shown low sensitivity, such as that by George et. al. Sensitivity
levels have been reported to demonstrate atto-farads per mm H2O, which
necessitates on-chip processing electronics to minimize parasitic capacitance.
Further, the literature reports capacitive based sensing is subject to drift resulting
from biomatter adsorption onto the sensor’s plates and non-condensing moisture
intrusion [72, 88, 100]. Microstrain sensing, however, has a proven history of
acceptable clinical use for ICP, short of long-term drift, providing a proven
biocompatible interface for CSF and brain tissue. Barlian et al. found that
piezoresistive sensing provided distinct advantages over capacitive sensing
including ease of differential configurations and freedom from film stress related
errors and surface micromachining yield challenges [101]. In consideration
toward accomplishing the goal of this work, microstrain sensing will be chosen as
a potential solution.
Metallic Strain Sensing
Microstrain pressure sensors are based upon measuring the strain incurred by
the deflection of a pressure diaphragm. The shape of the diaphragm is arbitrary,
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but usually takes the form of a circle or square. Metal diaphragms were originally
employed, continuing into the 1970’s, with strain gauges bonded thereupon by
epoxies, phenolics, or eutectics [102]. Popular to early applications, and prior to
piezoresistive sensors, strain was quantified by measuring the conductivity of a
resistive metallic foil pattern joined to the diaphragm substrate. Figure 10
illustrates an example resistive pattern in which two electrical terminals are
provided to the left of the figure, which are connected to an interwoven
conductive design. The resistivity of the segments is given by Ohm’s law:

𝑅

𝜌

𝑙
𝐴

where ρ is the specific electrical resistance of the metal, l is the length, and A is
the conductor’s cross-sectional area. When lateral forces (i.e. horizontal to the
page) extend the design, the interwoven conductive lines become elongated,
increasing the length of each resistive segment and correspondingly decreasing
the cross-sectional area, which altogether increases resistance. Alternatively,
when lateral forces compress the design, the resistive lines broaden and shorten,
thereby decreasing resistance [103]. The serpentine layout serves to increase
the gain of the sensor since stress applied to the sensor not only affects one
resistive segment, but multiple parallel segments in series over a relatively small
sensing area.
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Figure 10 – Conventional metallic micro-strain resistive pattern.
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The gauge factor is essentially the gain of the device providing the change in
resistance for an applied stress resulting in strain. The gauge factor is defined
as:
𝜕𝜌
𝜌
𝜀

𝐺𝐹

where ε is the applied strain to the device.
Piezoresistive Strain Sensing
In 1954, Charles Smith observed and described the piezoresistive effect in silicon
and germanium semiconductors, providing a change in resistance upon applied
stress [104]. The piezoresistive effect for n-type silicon was thereafter further
described by Herring's theory of the many-valley conduction/valence-band model
[105].The model explained that crystal lattice strain disperses carriers across
several valleys (up to six in silicon aligned with three <100> directions), which
perturbs the longitudinal and transverse average mass. Compared to the
unstressed lattice, this leads to an isotropic overall effective mass, m*. Strain is
theorized to alter the energy band curves to effectively change the mass and,
hence, the conductivity. Depending upon whether carriers are dispersed to lower
or higher conduction states, changes in effective mass will result in either a
decrease or increase in resistivity. The mechanism of the p-type piezoresistive
effect has largely remained uncertain, until recently, due to the complexity of its
valence band structure. However, recent theoretical approaches attribute the
effect to a similar mass change from band warping and splitting [101].
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The piezoresistive coefficient relates the fractional change in resistance to the
applied stress. The coefficients, π, necessitate four subscripts since they relate
two second-rank tensors, stress and resistivity. The first subscript refers to the
direction of voltage measurement, the second to current flow, and the third and
fourth to orthogonal stress components. However, in the most common case,
where the direction of current flow and applied stress may be parallel or
perpendicular to each other, and oriented in the <100> or <110> crystalline
lattice directions, the net change in resistivity may be written as the sum of the
parallel and perpendicular effects. As such, a diffused resistor subjected to
parallel and perpendicular stress components σ‖ and σ┴, respectively, the
resistance change is given by:

∆𝑅
𝑅

π‖ σ‖

π┴ σ┴

where π‖ and π┴ are the piezoresistive coefficients parallel and perpendicular to
the resistor length. It can be shown that the piezoresistive coefficients π‖ and π┴
can be derived for any arbitrary crystalline direction from the π11 (typical of ntype), π12, or π44 (typical of p-type) [101, 106]. The advantage of piezoresistors
over conventional metallic strain sensors, other than direct implantation, is that
the gauge factor can be 50 – 100 times larger, or more [107, 108]. The
magnitude of the piezoresistive effect varies with crystal orientation of the
resistor. In order to maximize sensitivity piezoresistors are typically oriented in

64

the <100> direction for n-type doping and <110> direction for p-type doping [106,
107].
The first commercial devices were introduced in 1958 with early applications
primarily targeted toward biomedical and aerospace applications [102]. The
development of silicon and germanium piezoresistive strain sensors facilitated
pressure sensors with either strain sensors applied upon a sensing diaphragm or
within the diaphragm itself. Pressure sensing diaphragms with strain sensing
elements applied thereupon suffered from poor stability arising from factors such
as thermal mismatch and adhesive creep [102]. Single crystalline diaphragms
with diffused piezoresistors quickly disrupted the former market providing
superior diaphragm properties negating hysteresis and creep formerly found in
metal diaphragms. For thin silicon or germanium diaphragms with small
defections, the resistance change is linear with applied pressure, being perfectly
elastic at temperatures less than 500°C. Higher volume, lower cost applications
thereafter quickly followed.
Pressure Transduction
Pressure transducers utilizing a diaphragm with strain gauges typically employ
four strain sensors forming a Wheatstone bridge [109]. The Wheatstone bridge
configuration has been shown to be the optimal configuration for minimal
detectable pressure signals in a diaphragm [110]. The diaphragm is usually
designed such that two strain sensors increase in resistance upon incident
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pressure, while the other two sensors decrease in resistance, thereby increasing
the gain of the overall transducer.
Figure 11 illustrates an electrical schematic of a pressure transducer’s resistive
strain sensors arrangement into a Wheatstone bridge. Strain sensors designated
by R1 and R3 decrease resistance upon positive incident pressure to the
transducer’s diaphragm. R2 and R4, however, increase resistance and
therefore, in combination with R1 and R3, improve the sensitivity of the
transducer. In this configuration, the optimal piezoresistive diaphragm would be
one that produces relatively high stress levels in response to incident pressure, a
large delta between longitudinal and transverse stress, and relatively small
spatial stress gradients over the piezoresistor implant locations [106]. From
Figure 11, by letting Vo = +Vo – (-Vo) and a supply voltage of Vs = +V – (-V), it
can be formulated from the schematic that:

𝑉

𝑉

𝑅
𝑅

𝑅
𝑅

𝑅

𝑅

The output voltage is zero when the bridge is in balance according to the
condition:
𝑅
𝑅

𝑅
𝑅
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Figure 11 – Wheatstone pressure transducer comprising strain sensors.
A change in resistance for each of the four strain sensors results in:

𝑉

𝑉

𝑅

𝑅
𝛥𝑅

𝛥𝑅
𝑅

𝛥𝑅

𝑅

𝑅
𝛥𝑅

𝛥𝑅
𝑅

𝛥𝑅

If R1 = R2 and R3 = R4 then expanding the equation above and substituting
provides:

𝑉

𝑉

𝑅 𝛥𝑅
𝛥𝑅
𝑅 𝛥𝑅
𝛥𝑅
2𝑅 𝛥𝑅
2𝑅 𝛥𝑅
4𝑅 𝑅
2𝑅 𝛥𝑅
2𝑅 𝛥𝑅
2𝑅 𝛥𝑅
2𝑅 𝛥𝑅

By making an assumption that ΔR/R << 1 and that Rx•ΔRy << Rx•Ry, then the
expression above can be shown [111], with corrections, to simplify to:
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𝑉
𝑉

1 𝛥𝑅
4 𝑅

𝛥𝑅
𝑅

𝛥𝑅
𝑅

𝛥𝑅
𝑅

and by utilizing the gauge factor, GF, the expression further simplifies to:
𝑉
𝑉

𝐺𝐹
𝜀
4

𝜀

𝜀

𝜀

Therefore, this simplified derivation relies upon two important points: that the two
bridge leg resistances are equal, and that R is quite large such that ΔR/R is very
small. Furthermore, in order to negate offset and temperature effects, it is
preferable that all four bridge resistances be equal [103].
Modern micro-electro-mechanical systems (MEMS) commonly provide monolithic
piezoresistive implanted pressure diaphragms fabricated using micromachining
etchants. Prevalent pressure sensor types include both bulk micromachined
monocrystalline silicon as well as surface micromachined polysilicon employing
thin-film depositions. There are additionally some pressure sensors which are
fabricated from bonded metal foil. Monocrystalline silicon material possesses
excellent mechanical qualities described by Petersen encompassing high
strength, high stiffness, high reliability, high Q, high precision, and with low
mechanical hysteresis [112, 113]. Surface micromachined materials, however,
do not possess the same high-quality properties. They are usually comprised of
polycrystalline or amorphous thin films with existing material stress or
unfavorable energies [102]. Nonetheless, the advantage of thin-film deposition
lies within the opportunity for CMOS integration using a two-step process first
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leveraging mainstream CMOS fabrication with subsequent MEMS specific
processing [113]. Contemporary MEMS technologies employ a variety of silicon
including bulk silicon (Si), silicon on insulator (SOI), silicon on sapphire (SOS),
and silicon carbide (SiC), as well as additional materials such as steel, carbon
nanotubes (CNT), and even diamond for critical rugged environments [114].
Common MEMS pressure sensor fabrication techniques encompass isotropic
and anisotropic etching, diffused or ion implanted resistors, and various forms of
bonding ranging from anodic to direct.
TE Connectivity (previously Measurement Specialties) produces a range of
MEMS pressure sensors, formerly offered in bare die, in both absolute and
differential configurations. The closest pressure range devices offered by TE
Connectivity sought by this work are the 1620 and 1630, which utilizes
piezoresistors, providing a -50 to 300 mmHg (-680 to 4,079 mm H2O) range.
Figure 12 shows the 1630 and its cross-sectional diagram.
Sensitivity of the devices are specified at 368 nV/V/mm H2O. The 1630 device is
marketed for use as a biocompatible and temporarily implantable pressure
sensor, favorably offering connections on one side of its ceramic substrate. The
sensor utilizes film resistors on the printed circuit board (PCB) substrate allowing
laser trimmed temperature compensation. Input resistance is specified between
1.2kΩ and 3.2kΩ with output resistance between 270Ω and 330Ω. For liquid
media compatibility, a dielectric silicone gel is provided over the topside of the die
for fluid isolation. The life of the device is limited to 72 hours. The company also
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Figure 12 - TE Connectivity 1630
(Source: TE Connectivity)
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offers several 0 – 1 PSI sensors. However, TE Connectivity does not offer any
matched die configurations, which will later be shown imperative, nor bipolar
devices in the desired pressure ranges. The operating pressure range of the
16** series is greater than 8x the desired range of this work’s goals, thereby
likely diminishing desired resolution.
The Sensor Technology Group of Amphenol produces biocompatible pressure
transducers based upon bulk micromachined monocrystalline piezoresistive
sensors. The sensors are marketed for low drift performance utilizing what the
manufacturer markets as trade secret construction that alleviates long term
mechanical creep. Very important to this research, as will be explained
hereafter, is that Amphenol produces matched die configurations. Their All
Sensors millivolt series, being passive only, allows for customized voltage bias,
which is desirable for low voltage operation to reduce quiescent power conditions
in the transponder design as well as ease requirements of telemetry power
transfer.
Various ranges are offered by Amphenol within the span of several inches of
water pressure. The 30 INCH-D-MV operates within the ±30 inches H2O (i.e. 762
mm H2O) and has a corresponding full-scale output signal between 19 and 21
mV with 20 mV typical at 12V bias (i.e. 2.19 µV/V/mm H2O). The sensor module
is marketed for use with non-condensing gases, likely due to both top-side and
bottom-side die fluid contact. However, for this research, only bottom-side die
will be used for liquid media contact. Amphenol specifies the sensor for long
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term drift of ±100µV over a one-year time period. Translated over the full-scale
range of the device, this figure suggests an expected drift of ±3.8 mm H2O per
year. The device is temperature compensated with laser trimmed resistors and
can be parylene coated, offering an additional and optional biocompatible
interface with excellent moisture and chemical barrier properties [115].
Specifications indicate the bridge resistance (i.e. input) for its combined dual
sensor configuration is 4.5kΩ with an output of 1.5kΩ, which as shown later,
results in an average of 1.5kΩ per piezoresistor. Compared to TE Connectivity,
this sensor utilizes a higher strain resistance, which improves linearity as shown
within the bridge derivation above whereby a ΔR/R << 1 results in the output
essentially becoming a product of the strain, ϵ, and gauge factor, GF. Further,
when compared with TE Connectivity, the 30 INCH-D-MV provides larger gain at
2.19 µV/V/mm H2O since the sensor’s span is 762 mm H2O versus the
unnecessary large range of the TE Connectivity 1620/30 (4,079 mm H2O) at
0.368 µV/V/mm H2O, resulting in a 6x improvement. The 30 INCH-D-MV
provides a sufficient proof pressure of 5,080 mm H2O, which is well beyond
physiological ICP pressures or normal atmospheric variations. Burst pressure is
specified at greater than 20,000 mm H2O. Finally, Amphenol is the only
manufacturer to specify low pressure long-term drift values in which the values
may be acceptable for ICP monitoring if indeed proven with liquid media.Figure
13 shows a microphotograph of one of the 30 INCH-D-MV Amphenol dies. The
silicon die is a monocrystalline bulk micromachined pressure sensor utilizing
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Figure 13 – Amphenol All Sensors 30 INCH-D-MV pressure sensor die,
approximately 2 mm2.
(Source: All Sensors Corporation)
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a square diaphragm. The diaphragm is specialized in that it consists of two
monocrystalline monolithic layers, being etched top-side and bottom-side to
result in a sensitive stress concentrated design. The process is proprietary and
partially described in Sensym’s U.S. Patent 5,178,016 as a sculptured diaphragm
[116].
Piezoresistors are implanted in locations of the thick upper relief shelf, forming a
Wheatstone bridge. The custom diaphragm increases bending moment at the
location of its shear sensing elements through the load of its thin portion of the
diaphragm, which is suspended by the periphery and thicker relief elements.
Thinner diaphragms enhance sensitivity whereas thicker diaphragms improve
linearity due to lower deflections, consistent with small deflection theory [114].
Unlike other silicon piezoresistive sensors, the Amphenol device does not utilize
a surrounding boss structure. Bossed structures increasingly suffer from position
sensitivity arising from the acceleration of gravity’s influence upon the very
sensitive diaphragm’s mass necessary for low pressure sensing.
The Amphenol die employs six implanted resistors within its upper relief. As
shown in Figure 13, the center horizontal thick relief pair (dark color) contains two
resistors beginning at the left edge of the diaphragm, which are connected in
series. In the center, are two more piezoresistors, which are additionally
connected to another set of series resistors at the right edge, forming a
Wheatstone bridge. Note, in Figure 13 the lower-left arm of the thicker relief is a
split circuit for ground, or negative connections to the die. This split circuit
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divides the Wheatstone bridge into two, allowing better balancing and zeroing of
the device. Figure 14 shows a microphotograph side view of the 30 INCH-D-MV
sensor. The sensor’s silicon support structure, which contains a bottom-side
machined cylindrical orifice, is bonded to its ceramic PCB substrate with a white
adhesive. The adhesive is likely comprised of a low-stress silicone acting as a
buffer against thermal mismatches between the two materials. Other
biopressure sensors in the literature have used Corning RTV 3140 silicone, for
example, which has demonstrated minimal thermal mismatch stresses with
silicon [117].
Thereupon the silicon support structure is the pressure sensor’s monocrystalline
silicon die with an upper single crystal epitaxial layer. The intermediate diffused
marking is a tooling artifact and not present on all sides of the die. The
fabrication process is described by Dauenhauer (the manufacturer’s co-founder
and co-inventor of CoBeam2 technology) and Reimann in U.S. Patent 5,178,016
Figure 8, in which the sensor’s diaphragm thickness is approximately that of the
epitaxial layer [116]. Further described within the patent is the sculptured
diaphragm’s upper relief containing a 3,000 Angstrom thick chromium metal layer
formed by sputter deposition. Figure 15 shows the wire bonded die mounted on
its ceramic PCB substrate secured and sealed by the white flexible adhesive.
The bottom of the PCB provides an orifice for fluid communication to the die’s
opposite/bottom side diaphragm. Figure 16 shows nearby film resistors, having
been laser trimmed (horizontal score mark) for precise balancing of the bridge.
75

Figure 14 – 30 INCH-D-MV side view at 40X (photo border provided for clarity).

Figure 15 - Amphenol sensor die deployment upon ceramic PCB with
soldermask.
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Figure 16 – Laser trimmed film compensation resistors.
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As shown in Figure 13 and Figure 15, the Amphenol die is anisotropically etched
to produce a square diaphragm. Clark and Wise derived the governing
electromechanical equations for rectangular thin diaphragm silicon pressure
sensors using finite difference numerical methods [106]. The analysis revealed a
50% improved sensitivity for square diaphragms over circular implementations of
the same dimensions (i.e. square length equal to circular diameter).
Piezoresistive characteristics are key for maximizing sensitivity, including
location, physical size, conductivity and type, orientation, doping levels, and
temperature [101, 106, 118]. Under load, stress is highest along the periphery of
the diaphragm, both for rectangular and circular diaphragms. Stress, as a
function of position from center-to-edge, begins to gradually increase at the point
approximately two-thirds radial distance from the center. Beyond two-thirds
distance from the center, stress rapidly increases to a maximum at the edge,
where resistor placement is most sensitive [106]. Implanted piezoresistors
average stress over their geometry and for the Wheatstone bridge, maximum
pressure sensitivity is achieved using two parallel and two perpendicular resistors
in the <110> direction [68]. Accordingly, the diaphragm is oriented in the <110>
direction.
The physical size of piezoresistors presents a trade-off between reproducibility,
which increases with size, and pressure sensitivity as resistor size decreases.
From Figure 13 it can be seen that the Amphenol edge resistors, implanted
within the upper relief’s moment arm, are physically placed parallel to each other,
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yet in series by virtue of the adjoining edge metal. This arrangement maximizes
sensitivity of the edge piezoresistors to capitalize on the stress presented by the
diaphragm’s edge by implanting dual short resistors. The two resistors increase
resistance in series and, hence, maximize the gauge factor and gain of the
sensor.
The sensor manufacturer specifies an input impedance of 4.5kΩ and an output
impedance of 1.5kΩ for the sensor module, which incorporates two identical dies
connected in parallel. Therefore, the equivalent individual die input resistance
can be deduced to 9 kΩ with an output resistance 3 kΩ for each die. It can be
derived that for a balanced bridge circuit, with equal bridge resistors and equal
span resistors, the input resistance is given by any bridge leg piezoresistor plus
twice the resistance of either span resistor [119]. The output resistance is simply
the value of any bridge leg piezoresistor.
Amphenol provides a schematic representation of the bridge circuit with span
resistors for temperature and offset compensation on the power supply inputs.
These resistors are actually located on a separate printed circuit board located in
close proximity to the sensor die. Taking into account the series connected edge
piezoresistors, the actual die effectively consists of four overall bridge resistors.
The Amphenol sensor specifications indicate a typical settling time of 100 µsec or
less for 10 to 90% signal. Consequently, a delayed sampling, either during
testing/evaluation or in actual deployment, will be necessary to prevent an ADC
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conversion from occurring while the sensor is still yet settling from power up. In
an effort to minimize any error induced by sampling the sensor’s output signal, it
is desirable to understand the settling time of the sensor to less than 1% error.
The 10 to 90% rise time of a single time constant circuit is approximately:
𝑡

≅ 2.2𝜏

Since the sensor manufacturer specifies a 100 µsec 10 to 90% rise time, a single
time constant estimation was calculated. Substituting into the equation results in
a τ of 45 µsec. For less than a 1% settling, more than four exponential time
constants are required and therefore, five was chosen in order to arrive at a
metric necessary for a delay circuit. Five-time constants results in a delay of 227
µsec.
Since a single-time constant circuit can be configured from an equivalent resistor
and capacitor network, a capacitor value can be derived from the single time
constant equation of 100 µsec = 2.2•1.5kΩ•C, where C equates to 30.3 nF.
Decoupling the dies from parallel to independent sensors, the equivalent
capacitance for each die is 15.15 nF with an output resistance of 3kΩ.
Therefore, the single-pole bandwidth of each sensor die is approximately 3.5
kHz. The manufacturer’s model of the sensor is shown in Figure 17, while the
actual individual die’s bridge model is shown in Figure 18.
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Figure 17 – Amphenol published equivalent circuit.

Figure 18 – Derived Wheatstone bridge pressure sensor model.
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All considered, the Amphenol 30 INCH-D-MV die was selected for further
research and development within this work given the die possesses a sensitivity
of 2.19 µV/V/mm H2O, a span of ±762 mmH2O, variable low voltage operation,
and parylene biocompatibility in an area of approximately 2 mm2. Very
importantly, Amphenol can produce matched die components. With regard to
resolution, the sensor is specified with a linearity and/or hysteresis error of 0.05%
FSS, which equates to 0.38 mm H2O. Complete specifications of the device are
provided within the Appendix.
Sensor System Design
Koskinen’s research found that the Codman microstrain device demonstrated low
pressure drift, deemed clinically acceptable, whereas Piper concluded the
opposite regarding the Camino fiber optic system. Although microstrain devices
are indeed sensitive to thermal effects, silicon based microstrain devices offer the
opportunity for bandgap temperature compensation techniques or compensation
via resistors with offsetting thermal coefficients which may further be precisely
trimmed. Considering the sensor system altogether, the consensus from the
literature review is that microstrain devices present less drift in clinical
deployments. Therefore, this research will seek to advance upon these findings
for microstrain devices by further developing and evaluating means for
minimizing and/or mitigating residual inaccuracies within the sensing mechanism.
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Cross-Coupled Dual-Die Single-Reference Pressure Sensor
One such means for potentially reducing drift is by employing two piezoresistive
pressure sensors on a common substrate, such as ceramic. In such a
configuration, two pressure sensors may be arranged to encounter mechanical
stresses in common-mode and therefore negate, or offset, erroneous sensor
read-out effects. Such a system is described by Dauenhauer et. al. in U.S.
Patent 6,023,978 as a pressure transducer with mechanically cross-coupled
fluidic pressures stimulating two alternating sensor die faces with error
compensation further comprising electrically cross-coupled outputs of the two
sensors [120]. In this system, conceptually shown in Figure 19, one pressure
acts as a reference pressure (e.g. atmospheric) and another is the unknown
pressure under test.

Figure 19 – Illustrative cross-section concept of dual pressure sensors with each
P1 and P2 cross-coupled to top-side and bottom-side dies.
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In the dual sensor configuration shown in Figure 19, the sensor dies are colocated upon a common mounting substrate whereby stresses become common
mode. By virtue of the sensors’ cross coupled outputs, as shown in Figure 20,
the total output signal becomes the superposition of the two sensors, subtracting
out the common stress. In order to do so, each sensor’s transfer function must
be substantially identical to the other and therefore necessitates matched silicon
dies.
Performance matched sensors use die taken from the same silicon wafer, since
error characteristics are predominately process related [120]. Sensor dies
located within the same area of a wafer tend to have even further similar
performance characteristics. For matched sensor dies, two die are often
selected which are adjacent to each other during wafer dicing. Such dies
typically share the same effects of equipment registration (or misregistration as
the case may be), such as orientation for ion implantation and other localized
effects, including etch rate characteristics (evaporation rates, temperature
gradients, impurities, etch area exposure distribution, or loading, etc.). Adjacent
pressure sensor dies also typically possess substantially similar zero and gain
coefficients with temperature, being largely controlled by impurity concentration
of doped regions [121]. Selected dies are thereafter measured, and further
sorted if necessary, to verify equivalent transfer functions, including gain, offset,
and linearity over operating parameter ranges (e.g. pressure, temperature, bias,
etc.).
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Figure 20 – Cross coupled dual sensor configuration for error compensation.
Matched sensors are of importance in large systems necessitating differential
pressure measurements where sensors may not be co-located, otherwise
allowing one differential sensor. Additionally, matched sensors are important for
systems, such as that described herein, designed to eliminate common mode
interference.
In the Dauenhauer dual sensor configuration the pressure sensors are deployed
in differential pressure mode in which one sensor serves as a reference sensor
(e.g. atmospheric) to the second, which receives the pressure to be measured.
The technology was licensed by All Sensors Inc. from Honeywell Data
Instruments and thereafter commercialized under the CoBeam2 brand, which
was later acquired by Amphenol. For implantable use, the device would require
an absolute reference or reliable means of atmospheric sensing. Providing either
of these are challenging. One potential method may consist of a gas chamber to
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pressurize the reference port. However, this essentially becomes an absolute
pressure sensor, leaving the overall sensor configuration vulnerable to drift by
gaseous diffusion and leakage. An alternative option may integrate a large broad
subcutaneous liquid bladder connected to the sensor’s reference port in order to
normalize any parasitic pressure from localized tissue growth yet communicate
atmospheric pressure on average. However, for ICP measurements, CSF
pressure is position dependent. Therefore, such a reference bladder would
produce one differential pressure in one position and yet another differential
pressure in a second position due to a changing reference, rendering the true
CSF pressure elusive.
Independent Dual-Die Dual-Reference BioPressure Sensor
One solution for obtaining the benefits of a matched dual-die pressure sensor
configuration is to actually decouple the two sensors and provide a common
absolute reference as shown in Figure 21. In this configuration, the sensor
system provides two matched pressure sensor dies with a common pressure
reference, yet two independent sensors, as shown in Figure 22, for measuring a
reference pressure and, separately and independently, cerebrospinal fluid.
The specifications and deployment of the dual biopressure sensor are described
in U.S. Patent 9,668,663 as a result of this research, with other patents pending.
The design may utilize a ventricular catheter, or alternatively a parenchymal
pressure bladder, for fluid communication with a brain’s ventricles as illustrated in
Figure 23 [47].
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Figure 21 - Independent dual sensor with absolute reference configuration for
error compensation.

Figure 22 – Independent output dual sensors with common power/bias rails.
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Figure 23 – Biopressure transponder deployment with ventricular catheter.
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Figure 24 illustrates the alternative fluid bladder pressure transducer for
parenchymal measurements, which may reduce dependency on flow or slit
ventricle complications in sensing pressure. The reference port would employ a
peritoneal catheter, providing an a-priori saline column serving as a known
position dependent pressure reference. The peritoneal catheter’s ability to
provide such a position dependent pressure reference, being a function of fluid
density and length, has been well characterized. Since the 1960’s, when
ventriculoperitoneal shunting became standard practice in the U.S., siphoning
began to be researched as a result of its undesirable impact for inadvertently
activating shunt valves, resulting in dangerous CSF over drainage effects [96,
122]. Ironically, this siphoning effect may be advantageously utilized as a
predictable in-vivo pressure reference source. Complications of peritoneal
catheters are rather rare with the most common issues reported being abdominal
pseudocyst or hepatic pseudocyst formation. The incidence of these
complications ranges in the literature from 1 – 4.5%. However, these
complications are thought to be associated with CSF shunt infections or from
multiple abdominal surgeries [123]. In the case of the biopressure sensor’s use
of the peritoneal catheter, specifically as a pressure reference, no CSF will be
discharged, notwithstanding a separate peritoneal catheter for CSF shunting
purposes. The distal end of the sensor’s reference catheter is intended to be
open, terminating into the peritoneum, subject to atmospheric pressure.
Alternatively, the catheter may simply be implanted in the subcutaneous plane
since no fluid drainage is intended to occur.
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Figure 24 – Alternative transponder deployment with fluid bladder as a
parenchyma pressure transducer.
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Walker and Criddle’s research on the pathophysiology of abdominal
compartment syndrome [124] found that the peritoneal cavity normally resides at
atmospheric pressure, which was also reported by Drake [3]. The route of the
peritoneal catheter, just subcutaneous, from head to abdomen, is also generally
at atmospheric pressure, particularly when taken as the average over the
catheter’s length. In this configuration, as shown in Figure 25, the reference port
pressure will be equal to atmospheric, or at a prescribed pressure near
atmospheric depending upon routing, in a patient’s supine position and
approximately -ρgh in the upright position.
In considering each sensor independently and as an absolute pressure sensor
with a common reference gas, physiological pressures would be in addition to a
full range of possible barometric conditions. Extreme ranges can span from 0.86
atmospheres up to 1.06 atmospheres [125, 126, 127]. These pressures correlate
to an absolute pressure sensor capable of 8,872 mm H2O on the low end up to
11,472 mm H2O for the highest recorded atmospheric pressure including 500 mm
H2O. However, as will be later shown, appropriate configuration of the dual
pressure sensor’s common absolute reference under typical conditions (e.g. the
mean) results in an acceptable response.
Given the sensor outputs are independent, the gain of the reference sensor can
be determined by reading the absolute pressure of the reference column in two
patient positions (e.g. supine, or 0°, and upright, or 90°) as follows:
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Figure 25 – System deployment of biopressure sensor with reference fluid
column and shunt integration (shunt peritoneal catheter shown).
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Next, for offset correction, since the reference port is subject to atmospheric
pressure and the sensor is read-out in absolute mode, the output will equal the
barometric pressure with the patient in the supine position (or barometric less
ρgh•cos(θ) in any other position). With a known input pressure (i.e. barometric)
being accurately measured ex-vivo via a calibrated barometer, a sensor offset
can be derived as follows:
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* where Patm is measured ex-vivo via a calibrated barometer.
Utilizing matched sensor dies enables the corresponding CSF sensor’s gain and
offset values to be determined via the reference sensor. Therefore, once the
system undergoes calibration by means of its reference sensor and peritoneal
catheter reference, accurate CSF measurements may be obtained which are
compensated for gain and offset drift by:
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Deployment and Implantation
Figure 23 illustrates the general approach of the transponder and its sensors for
human implantation, which in the embodiment shown, an integrated shunt is
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provided. As indicated within the literature, ventricular cannulation remains the
“gold standard” of ICP measurement. Hydrocephalus patients who undergo
ventriculoperitoneal shunting possess ventricular catheters often infection free for
years. Therefore, this design will incorporate a subcutaneous pressure
transducer implanted just underneath the scalp, connected to a ventricular
catheter, or alternatively a parenchymal bladder.
Figure 23 shows a right-angle connection to the ventricular catheter which also
facilitates shunt flow of CSF to its terminal site (e.g. the peritoneum, pleura, or
atrium). These types of catheters are typically of one-millimeter inner diameter
Silastic® (i.e. silicone) with a hardness commonly around 65 Shore A. Due to the
soft material, they may remain compliant, even when occluded, and, in a closed
pressure system, may partially transmit ICP to the transponder. Ventricular
cannulation also allows for the transponder’s implant site to be remote, just under
the subcutaneous plane of the scalp, for improved telemetry coupling compared
to a deep implant.
Additionally, shown in Figure 23 is the transponder’s reference fluid column
comprising a saline solution. The reference lumen connects to the transponder’s
Reference Sensor #1, as shown in Figure 21, to provide a position dependent
pre-known pressure reference. The transponder is anticipated to be titanium
construction utilizing glass-to-metal seals for integrating the telemetry antennas,
which are external to the transponder housing, yet subcutaneous. The
transponder’s signal antenna will carry the pressure signal while a second
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antenna will facilitate inductive power coupling. Although the design, given its
subcutaneous placement, could possibly utilize optical coupling, hair upon the
scalp could significantly impede such an approach. Therefore, this design will be
slated for electromagnetic telemetry for both power, via inductive coupling, and
high-frequency near-field pressure readout communications. The transponder
may therefore be entirely passive without any internal power source.
Supporting non-invasive readout of pressure, the transponder may utilize
Bluetooth LE for low-power digital communications. Bluetooth LE is compatible
with modern smartphones and thereby facilitates easy readout on readily
available multipurpose devices. Several smartphones, including the iPhone 6 or
later, include a barometric sensor, which may be utilized for offset correction.
Figure 26 provides a block diagram of the transponder’s electronics whereby the
pressure sensor is amplified by a low power instrumentation amplifier (IA). The
IA output is fed into a Texas Instruments microcontroller’s analog input. The
CC2541 integrates a Bluetooth LE transceiver and Bluetooth software stack.
Separately, the Texas Instruments BQ500210 and ST Microelectronics
STWLC04 chipset provides a telemetry control unit and receiver for
transcutaneous inductive powering of the transponder. The ST Microelectronics
STWLC04 is optimized for 1W power transfer providing an approximate 60%
efficiency, thereby lowering the required transcutaneous energy transfer versus
other receivers.
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Figure 26 – Transponder and readout deployment block diagram.
(research focus outlined in blue dotted line)
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Electronics Readout Overview
Readout of the ICP pressure sensors, described in prior sections, is comprised of
a two-part assembly. The first encompasses the ex-vivo powering and
demodulating unit for physician or patient use and interpretation. This
functionality may take advantage of smartphone integration utilizing a Bluetooth
LE enabled device to provide communication and a user interface while a second
module transcutaneously powers the transponder. The second part of the
system consists of the implantable pressure transponder, which contains the dual
biopressure sensor and receives power from the first system, responding with a
Bluetooth LE encoded pressure signal. The transponder’s pressure sensor(s),
and specifically its limitations of accuracy, are the object of research within this
work.
Figure 26 lays out the general approach of the pressure transponder and readout
mechanism. The front-end analog electronics consists of an instrumentation
amplifier which then supplies an amplified analog representation of pressure to
the analog-to-digital converter (ADC) of the microcontroller. Amplification of the
sensor’s low voltage signal is necessary to produce an adequate signal-to-noise
ratio with a low output impedance voltage driver for the ADC.
Each sensor’s output is a differential signal generated by the Wheatstone bridge
strain gauge supplying an amplifier with a very high input impedance which
minimizes input loading effects. Since the sensor’s output signal is 2.19
µV/V/mm H2O, a high gain is needed very close to the sensor in order to boost
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an unadulterated sensor signal above the noise floor present within the
remainder of the transponder’s circuit. Since the pressure sensor is intended to
operate within a relatively stable pressure environment and with a sample and
read approach, a low bandwidth analog channel is all that is required, which
helps reduce power and noise. With these considerations in mind, an
operational amplifier topology was evaluated in a differential mode. Figure 27
shows the topology of an operational amplifier differential configuration. The gain
of the amplifier, for Rf = Rg and R1 = R2, is given by:
𝑣
𝑣

𝑣

𝑅
𝑅

Figure 27 – Operational amplifier differential configuration.
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and the input impedance is:
𝑅

𝑅

𝑅

Since this design is seeking a very high input impedance, as well as a high gain,
it can be seen that in order to have a high gain with a high input impedance, Rf
would quickly become extraordinarily large. A large resistance can be
challenging to control and in the deployment of an implantable transponder, such
a large resistance determining the gain could become detrimental when
considering any possible moisture intrusion that may affect its value.
An alternative approach to buffering the sensor’s differential signal is the use of
an instrumentation amplifier as shown in Figure 28. For a CMOS or JFET
instrumentation amplifier, the input impedance looking into the non-inverting
inputs are nearly infinite with extremely low bias currents and therefore the gain
of the amplification stage is independent of the input signal’s impedance. The
second stage of the instrumentation amplifier is simply the differential amplifier of
Figure 27. The gain of the instrumentation amplifier can be shown [103] to be:
𝑣
𝑣

𝑣

𝑅
𝑅

1

2𝑅
𝑅

Therefore, the gain of the amplifier can be adjusted by one resistor, which is
typically external for instrumentation amplifier integrated circuits (IC). In addition
to very high input impedances and a topology allowing high gains, it can also be
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Figure 28 – Instrumentation amplifier.
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shown [103] that the instrumentation amplifier possesses very high commonmode rejection (i.e. ≥ 100 dB typically) in cases where the amplifiers gain
resistors are very well matched, as is typically the case in modern ICs. An
additional benefit of the instrumentation amplifier is the node presented by R3,
whereby a ground connection can be substituted with an offsetting reference.
This feature is attractive for allowing low voltage operation of the transponder
whereby bipolar operation of the pressure sensor can be achieved using only a
positive power supply by establishing an offset ground/common node (e.g. at
2.5V). The downside of the instrumentation amplifier is that it can be more power
consuming and potentially more expensive.
A search was conducted for a low power, low offset voltage instrumentation
amplifier with a high gain potential to mitigate the transponder’s typical noise
floor. Table 3 shows a narrowed selection of instrumentation amplifiers from
Texas Instruments (TI) and Analog Devices (AD). The selection was narrowed
based upon low power and then evaluated for other requirements. Although the
INA-126 offers the lowest quiescent current of all considered, it also presents
highest noise figure and least immunity. The INA-141 was used in prior
biopressure sensor research due to its low noise figure, high CMRR, and very
low offset voltage and was further used in long-term testing later described [128].
However, the AD8222 was discovered to further offer higher performance in each
of these categories, only sacrificing maximum power supply at 18V versus 36V
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Table 3 - Low power instrumentation amplifiers.

TI INA126

TI INA141

Vcc (max)

36

36

36

18

V

Vcc (min)

2.7

4.5

4.5

2.3

V

Input Bias Current

25

5

5

1

Input Offset

3.0

0.5

0.5

Noise @ 1kHz

35

8

8

8

CMRR

83

117

120

126

Non-Linearity (max)

0.002

0.002

0.002

0.002

Bandwidth @A=100

9

200

200

140

kHz

Quiescent Current, Iq

0.175

0.750

0.700

1.000

mA
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TI INA129-EP

AD 8222

nA

0.3 μV/°C
nV/rt(Hz)
dB
%

and bandwidth at 140 kHz versus 200 kHz, of which neither parameter was
unacceptable for the sensor application.

Methods
This section describes the methods for simulation and evaluation of the new
sensor design described within the Approach. Of key interest is the evaluation of
drift mechanisms and any mitigating results of the new sensor and its calibration
method. This section outlines the methods for verifying the requirements and
objectives given by Table 2.
Simulation
As referenced in the Sensor Technology section of the Approach, in order to
negate the sensor’s offset and piezoresistor temperature response, all four
bridge piezoresistors must be near equal. While ratio matching of diffused
piezoresistors is quite good relative to absolute tolerancing, it is nevertheless
imperfect. Based on the literature review, regional brain temperature gradients of
0.4°C were found extending from the brain’s surface to the ventricles.
Additionally, temperature variations of 0.2°C were measured over the circadian
cycle. Although small, the effect of these variations must be evaluated with
respect to the sensor’s pressure transduction. To examine any potential impact
upon offset or from temperature swings, the resistance of several piezoresistors
will be measured to assess the typical extent of possible mismatch. Additionally,
the piezoresistors’ thermal coefficient will be determined by temperature testing
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in the laboratory. With these values, PSPICE circuit simulations will be
conducted to assess the extent of any impact upon pressure transduction.
Additionally, thermal simulations will be conducted using COMSOL to evaluate
any concern from potential Joule heating of the sensor itself upon CSF or
surrounding tissues.
Sensor Evaluation
Sensor testing will entail two primary methods. First, the specified Amphenol
matched silicon dies with input cross-coupling and output summing (as produced
by the manufacturer), shown in Figure 20, will be evaluated uncorrected, to
examine long-term inherent drift performance (hereinafter referred to as
Uncorrected Sensor Drift Assessment). Secondly, a custom sensor will be
developed using two matched dies independently configured as sensors sharing
a common absolute gas reference and substrate as described within the Sensor
Design section and as illustrated in Figure 22 and Figure 23. The system will be
laboratory evaluated as next described (referred to as System Calibrated Sensor
Assessment) and in accordance with the operational methods described in the
Sensor Design section and in U.S. Patent 9,668,663.
Uncorrected Sensor Drift Assessment
The native sensor drift of matched dies in a cross-coupled and output summed
configuration will be evaluated over an extended period of time using the setup
shown in Figure 29. The Amphenol BLVR-L30D-B1NS will be selected for most
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Figure 29 – Long term drift chamber with external and local power supply
regulation and thermal stability with data acquisition system under UPS.
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closely matching the desired pressure range of -500 mm H2O to +500 mm H2O
and to represent state-of-the-art driftless sensing. The laboratory setup will
employ a temperature chamber to maintain a stable operating environment
throughout the evaluation. The temperature will be set to 37°C, simulating
human in-vivo temperature. Liquid media input pressure will be provided via a
glass cylinder of water. Figure 30 is a schematic of the front-end analog
electronics to be used for amplifying the sensor signal. The circuit will utilize
precision linear voltage regulators in addition to an external precision power
supply. As provided in the schematic, the Amphenol dual matched-die utilizes
cross-coupling of the input pressures to opposite sides of the two dies.
Furthermore, the outputs of the two separate dies are summed prior to
amplification. This design and configuration currently represents the most
advanced commercial device for actively reducing drift. Periodic measurements
will be obtained via a data acquisition system (DAQ) as well as periodic manual
measurements. The entire system will be sustained via an uninterruptable power
system (UPS).
System Calibrated Sensor Assessment
The setup for evaluating the new custom sensor system’s ability to mitigate offset
and gain drift will entail emulating in-vivo pressure sources by utilizing a
reference fluid column (e.g. simulating a peritoneal catheter) and a CSF pressure
source. The two dies of the sensor system will be hydraulically connected with
pressure sources comparable to those in-vivo. Figure 31 illustrates a benchtop
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Figure 30 – Front-end circuit for long-term cross-coupled sensor assessment.
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Figure 31 – Dual biopressure sensor test bench with pressure source, precision power supply, instrumentation
amplifier, and oscilloscope measurement.
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test system incorporating a burette pressure source which will connect to the
CSF inlet port of the biosensor. On the biosensor’s reference inlet will be tubing
of liquid of a prescribed length terminating into a 2L water reservoir. The water
reservoir will simulate a large fluid mass representative of the peritoneum or
simply the subcutaneous plane. Gain drift will be induced by modulating the
sensors’ bridge voltage bias.
The overall sensor system, including the input pressure sources, will also be
enclosed within a vacuum chamber, as shown in Figure 32. This will allow
modulation of the environmental pressure, simulating either atmospheric
pressure changes common to the system or a drift of the sensor’s absolute
reference chamber, necessitating offset correction.
Figure 33 shows the schematic of the front-end analog circuit to be used for the
System Calibrated Sensor Assessment. Compared to the Amphenol
configuration shown in Figure 30, the two matched dies are decoupled
electrically and also distinctively share a common top-side absolute gas
reference. In this configuration, mathematical signal processing is performed
post amplification, which allows the sensors to be sampled individually over
different orientations/positions. For benchtop testing, precision power supplies in
close proximity to the system will be used for powering the sensor and test
circuits.
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Figure 32 – Isolation chamber with self-contained pressure source for offset
testing.
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Figure 33 – Front-end circuit for benchtop testing of system calibrated sensor.
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The evaluation protocol for the System Calibrated Sensor Assessment will be as
follows:
1. Bias the sensor: either to the nominal operating voltage (i.e. ±5.000 VDC)
or to an offset voltage (e.g. ±4.000 VDC or ±6.000 VDC), to induce a
known gain drift.
2. Measure the reference sensor and CSF pressure sensor’s amplified root
mean squared (RMS) output voltage with the reference pressure line and
water reservoir in the 0° position (i.e. zero pressure above atmospheric).
3. Measure the reference sensor’s amplified output voltage with the
reference pressure line in the -90° downward position (i.e. a pressure of
Patm – ρgh). Record the height, h, in addition to the output voltage.
4. Calculate the gain of the reference sensor using the known reference
line’s pressure, by virtue of knowing its length/height, liquid density, and
barometric pressure for the two positions.
5. With a calibrated barometer reading the station pressure (e.g. located
either within the vacuum chamber or deduced by a vacuum gauge and
barometer), measure the biosensor’s environmental pressure. A vacuum
pressure may be used to simulate a known pressure sensor offset.
6. Using the reference sensor’s RMS output signal from its reference
pressure line in the 0° position, along with the calculated gain, calculate
the sensor’s offset, b, by equating the signal measurement to the known
environmental pressure based on the calibrated barometer.
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7. Using the reference sensor’s gain and offset, calculate the CSF sensor’s
input pressure.
8. Compare the measured and corrected CSF inlet pressure to the known
true CSF input pressure (i.e. liquid level in burette or other source).
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CHAPTER FOUR
RESULTS AND DISCUSSION
In the prior chapter, sensor requirements and research objectives were
developed based upon research of the literature related to ICP monitoring for
hydrocephalus and other intracranial hypertension high risk patients.
Fundamental limitations in current pressure sensing technology for long-term
monitoring were identified and discussed. A new novel approach, patented as an
outcome of this research, was described and developed thereupon. Methods for
assessing the latest state-of-the-art driftless sensing technology and the new
novel approach described herein were developed. In this chapter, results of the
methods will be presented along with discussion related to the results and
challenges thereof. Chapter Five will assess the results overall with respect to
potential clinical impact and future steps.
This chapter is organized into: 1.) Sensor Simulations 2.) Uncorrected Sensor
Drift Results 3.) System Calibrated Sensor Results, and 4.) Non-Ideal Effects and
Challenges. The Sensor Simulations section provides results of PSPICE and
COMSOL thermal simulations. The Uncorrected Sensor Drift Results provides
an assessment of the latest drift-less sensing technology commercially available.
The System Calibrated Sensor Results section provides results of the new dual
sensor approach allowing self-calibration of the system to mitigate drift. This
section will provide results correlating to the objectives outlined in Table 2,
including pressure range, resolution, etc. Finally, the section on Non-Ideal
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Effects and Challenges will share several of the predominant challenges
encountered by this research and how they were overcome.

Sensor Simulations
Simulations of the sensor’s bridge circuit was performed using Cadence®
PSPICE. To properly model the bridge circuit, several unmatched sensor die
measurements were taken under controlled temperature to measure bridge
resistance. Table 4 shows the resistance of three different unmatched bridge
circuits whereby each bridge piezoresistor was measured at 22.1°C.
As can be seen from the table, the three different unmatched sensor dies
produced a large range of resistance compared die to die. This is due to the
inherent large parameter drift of diffused resistors in integrated circuit (IC)
processing which results in poor absolute accuracy [129]. However, the ability to
ratio match resistors in IC processing is much better, which can be seen by the
small deviation within each unmatched sensor die’s piezoresistor set. The
overall average piezoresistance among all resistors sampled was 2.602 kΩ.
Amphenol All Sensors modules utilize a second printed circuit board to provide
additional circuit resistance to produce consistent input and output resistance
and to trim sensor span. Furthermore, the additional printed circuit board
provides twin ground resistors which can be laser trimmed to balance the two
sides of the bridge and “zero” the output. These resistors connect to the split
ground as shown in Figure 13.
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Table 4 – Sensor bridge piezoresistance at 22.1°C.

Unmatched Sensor Bridge
A

B

C

R1

3,268 Ω

2,472 Ω

2,020 Ω

R2

3,345 Ω

2,496 Ω

1,998 Ω

R3

3,351 Ω

2,497 Ω

2,020 Ω

R4

3,273 Ω

2,466 Ω

2,023 Ω

AVG.

3,309 Ω

2,483 Ω

2,015 Ω

% DEV.

1.26%

0.57%

0.38%

To more fully model the characteristics of the sensor bridge, piezoresistance
measurements were taken over temperature. Figure 34 plots the acquired data
for a piezoresistor of 3.096 kΩ at room temperature with a temperature response
of 8.49Ω/°C, or 2,940 parts per million (ppm) per degree centigrade. The
temperature coefficient and measured resistance mismatch of the bridge’s
piezoresistors were used for simulating potential temperature and offset
inaccuracies of the pressure sensor. Figure 35 provides the schematic used for
PSPICE simulation using the worst deviation in bridge resistance given in Table
4. Piezoresistor temperature coefficients of 2,940 ppm were loaded for R1 – R4.
A simulation of temperatures ranging from 20°C to 40°C were ran. Figure 36
shows the resulting piezoresistance variation for R1 ranging from 3.276 kΩ to
3.473 kΩ. Figure 37 shows the resulting differential output voltage of the bridge
over the same temperature range.
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Figure 34 – Piezoresistor temperature response
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Figure 35 – Sensor bridge PSPICE simulation circuit for piezoresistor mismatch
and temperature sweep.
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Figure 36 – PSPICE simulation showing piezoresistance for R1 at 20°C, 36°C, 37°C, 38°C, and 40°C.
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Figure 37 - PSPICE simulation showing bridge output of 329.076 μV for all temperatures 20°C - 40°C.
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A noticeable offset voltage of 329 μV exists at the output, which is due to the
piezoresistors’ mismatch. Temperature variations, however, are almost entirely
negated by the full-bridge circuit, resulting in only several femtovolts over the
20°C range. Provided the nominal resistance of each piezoresistor is close, the
percent resistance change from nominal is negligible. Only in the presence of
temperature gradients does the bridge become unbalanced due to temperature.
However, temperature imbalances across the face of the die are unlikely due to
the heat capacity of the contacting liquid media and the small cross-sectional
area of the sensor.
A COMSOL simulation was created using the die and ceramic substrate
geometry to evaluate temperature gradients within the sensor body and any
impact upon the temperature of CSF. The simulation was constructed using
37°C water (99% CSF constituent) stimulating the bottom-side surface of the die.
Joule heating resulting from the piezoresistors at 5V bias was simulated. Figure
38 shows the resulting temperature gradient in which the surface of the die and
the contacting liquid is uniform at 37.248°C. At the chip’s ceramic substrate,
where the port meets the liquid column (or CSF), the temperature was found to
be 37.018°C. Therefore, from both the PSPICE and COMSOL simulation, the
device is both temperature stable and safe in-vivo with near zero heating impact
to CSF.
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Figure 38 – Temperature gradient from sensor’s Joule heating upon 37°C CSF.

Uncorrected Sensor Drift Results
The latest commercial technology available for drift-less pressure sensing was
found offered by Amphenol/All Sensors employing dual matched-die crosscoupled sensors. The BLVR-L30D-B1NS sensor was selected for evaluation to
assess the sensor’s drift performance. Although the sensor module incorporates
drift correction through the use of both cross-coupled fluid and cross-coupled
electrical signals, the sensor is otherwise uncorrected relative to this work’s selfcalibrating sensor system. By sharing input fluid under test with both sensors
and electrically cross-coupling the outputs, the two sensors module can subtract
out common-mode induced stress that could otherwise result in measurement
drift. Amphenol is the only manufacturer identified by this research to specify
long-term drift metrics, which for the BLVR in gaseous media is specified at 1.45
mm H2O at year one. The sensor drift was evaluated for over two years using
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the methods previously described in Chapter Three and with the laboratory setup
shown in Figure 39. The laboratory setup utilized a Test Equity TEC1
temperature chamber set to 37°C. Measurements for room temperature,
chamber temperature, and output voltage corresponding to pressure were logged
with a one-minute period using National Instruments’ LabView and the NI USB6211 16-bit 250 kS/s data acquisition system.
The pressure sensor was amplified by a Texas Instruments INA-141
instrumentation amplifier, which was locally regulated by LM1086 and LM337
linear regulators. The sensor’s readout circuit is shown in Figure 30. Local
precision power regulation was utilized to minimize any bridge bias voltage effect
upon drift. Power supply voltages and input fluid were routinely monitored to
ensure stability for negligible to zero impact upon drift measurements. The entire
system was further powered by an external Hewlett Packard E3620A precision
power supply and an uninterruptable power system (UPS). The sensor module
was configured with a glass cylinder epoxied to its ceramic printed circuit board
(PCB) for backside die pressure stimulation as shown in Figure 40. Epoxy
Technology EPO-TEK 730-110 was selected due to its use in other implantable
devices. An initial transfer function was taken prior to long-term testing and is
shown in Figure 41 revealing an amplified gain of 12.7 mV per mm H2O (or 127
μV unamplified) and with an offset of 0.7 mm H2O with excellent linearity of
0.60% full scale span (FSS).
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Figure 39 – Laboratory setup for uncorrected long-term drift measurement of
cross-coupled sensor.
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Figure 40 – Long-term test sensor with pressure cylinder and read-out circuit.
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Figure 41 – Uncorrected pressure sensor initial transfer function.
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Approximately 31 mm of water was used for pressurizing the system for longterm drift testing with a small top layer of mineral oil to mitigate evaporative
effects within the thermal chamber. 31 mm H2O was chosen as a moderate
pressure, relative to the overall pressure range of the device, to challenge the
sensor’s signal-to-noise performance while yet minimizing any small parasitic
pressure effects upon assessing true drift. Figure 42 graphs the average daily
pressure output for 862 days of testing (i.e. 2.4 years).
By day 27, the pressure sensor’s gauge factor lost 10% of its gain. A maximum
occurred at day 841 with a loss of 19.4% gain. A slight anomaly at day 628
represents when the thermal chamber was re-setup due to a facility move. The
liquid’s top layer of mineral oil was slightly tilted wetting the upper surfaces of the
cylinder’s interior. A drop of liquid was added to compensate. However, the
mineral oil slowly returned from the inner circumference of the cylinder settling
upon the top of the water, overall resulting in a 0.9 mm H2O increase in daily
average pressure. The sensor’s signal thereafter stabilized. However, over the
next five months the sensor’s output increased slightly before encountering
another significant gain loss, returning to the approximate gain prior to the
equipment move.
A linear fit overlaid on Figure 42 approximates a gross gain loss of 18.0% at day
862. A transfer function acquired shortly thereafter, at 2.5 years at 31 mm H2O
pressure stimulation, reveals a more precise 22% gain loss as shown in Figure
43. Nevertheless, linearity in the transfer function is nearly perfectly preserved at
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Figure 42 – Long-term uncorrected pressure sensor drift for 31 mm H2O liquid (BLVR-L30D-B1NS).
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Figure 43 - Uncorrected pressure sensor initial and 2.5-year transfer function.
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0.63% FSS (versus 0.60% originally) and with negligible zero shift with less than
1 mm H2O. Figure 44 shows the transfer function for two additional matched
sensor dies, which were used in fabricating a custom device. The figure shows
an uncorrected transfer function after six months at room temperature. The data
reveals an average decline in gain of 2.75% ±0.97%, with the difference between
the two dies totaling 0.65%. Offset drift was negligible. Extrapolated to 2.5
years, the estimated gain drift, should it remain constant, would equate to about
14%. In this different set of dies, the linearity is again preserved despite the loss
of gain. Linearity after six months was 0.74% FSS and 0.55% FSS for U1 and
U2, respectively.
Three-month baseline and sensitivity studies performed by the University of
Auckland, New Zealand, for a piezoresistive diaphragm pressure sensor, found
thermal bonding damage as a prime suspect for die level drift. Additionally, the
study identified diaphragm oxidation growth and the deterioration of its photoresistive layer as a contributor to changes in gauge factor, or gain [130]. Other
contributors included inelastic deformation of the diaphragm, effusion of the
absolute reference cavity, power-cycling thermal effects, as well as drift
mechanisms arising from DC bias. The preliminary study concluded that sensor
drift was found to be bilateral and unpredictable, making a priori design
compensation challenging. Esashi et. al. also studied specific drift factors in
custom fabricated piezoresistive pressure sensors [117]. Their findings identified
electrical leakage currents and thermal mismatch, particularly between the
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Figure 44 – Six-month drift results for dual pressure sensor build 0517
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sensor and its support or substrate, to cause drift. The study stated most of the
instabilities presented resulted from thermally induced stress upon packaging.

System Calibrated Sensor Results
Distinct from the Amphenol cross-coupled pressure inputs and summed electrical
outputs, this research evaluated decoupled inputs and outputs utilizing a
common absolute reference chamber with a second hydraulic reference and
novel calibration approach intended for in-vivo operation. The approach utilizes
matched silicon dies, as described in Chapter Three’s Independent Dual-Die
Dual-Reference BioPressure Sensor section, to evaluate gain and offset of one
sensor to predict the characteristics of the other matched sensor. A custom
pressure sensor module was constructed utilizing Amphenol’s 30 INCH-D-MV
matched pressure sensor dies. Figure 45 illustrates an exploded view of the
custom sensor where on the left-hand side of the illustration is the absolute
pressure chamber on top, which encapsulates the two top-side dies. At the top
right-hand side of the figure is shown independent pressure port chambers for
bottom-side stimulation of each die. The substrate in the middle upon which the
pressure sensor dies are mounted is a 1 mm thick ceramic PCB. As compared
to Figure 21, both dies share a top-side absolute pressure chamber source while
each die’s bottom-side diaphragms are interpedently stimulated.
The 30 INCH-D-MV dies are monocrystalline bulk micromachined silicon sensors
of approximately 2 mm x 2 mm area with a mating silicon support structure. The
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Figure 45 – Custom dual biopressure sensor exploded illustration.
dies are mounted bottom-side to their ceramic chip carrier via a low stress deep,
yet thin, layer of silicone. Single crystal silicon is the most commonly used
substrate for micromachined MEMS and has a long history of use in implantable
devices, including ICP monitors, such as the Codman Microsensor®, as well as
the NEUROVENT P-tel® and the Sensor Reservoir®. Kotzar at. al. examined the
biocompatibility of silicon MEMS, along with commonly associated materials,
such as titanium, over a range of ISO 10993 tests [131]. Titanium has long been
used in pacemakers providing hermetic enclosures incorporating glass-to-metal
seals [132]. Hermetic anodic bonding of bulk micromachined silicon pressure
sensors to glass has additionally been reported and demonstrated [91]. Corning
7740 (Pyrex®), Corning 7070, Corning 1729, Corning 9626, Schott 8330
(Tempax®) and SD-2 (HOYA) are all among the most prominent glass materials
given their close thermal coefficients to silicon [133]. Glass to metal seals’
biocompatibility has been examined to be robust [134]. Kotzar examined both
aqueous and non-aqueous physiochemical tests, cytotoxicity, extractables, and
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histopathology for explanted silicon and associated MEMS materials as well as
titanium materials. Kotzar further examined the test materials both poststerilization and explantation for in-vivo damage or alteration under scanning
electron microscopy (SEM). All tests results indicated safe biocompatibility,
including compatibility with prevailing sterilization techniques, such as gamma
and autoclaving, without damage to the materials. Silicone elastomer materials
have additionally proven a long history of biocompatibility, particularly in the
brain, where its first recorded CNS use dates back to the 1950’s by Robert
Pudenz and Richard Ames for use as long-term shunt catheters [135]. All
considered, the selection of the 30 INCH-D-MV die and associated materials, or
the additional choice of mating materials which may be used in the fabrication of
the finished implant, represent biocompatible materials with hermetic capabilities,
meeting the requirements of R1.0 and following objectives.
The 30 INCH-D-MV dies provide ±762 mm H2O of linear pressure range with a
proof pressure (i.e. maximum applied pressure without permanently changing
performance) of ±5,080 mm H2O (i.e. ±one-half atmosphere). Burst pressure of
the 30 INCH-D-MV die occurs at ±2.0 atmospheres. The 30 INCH-D-MV sensor
die outputs were mounted upon a ceramic substrate and independently bonded
and pinned out to a secondary printed circuit board, as shown in Figure 46.
Custom pressure sensor chambers were fabricated, as shown in Figure 45, from
Polymethyl Methacrylate (PMMA) for laboratory evaluation purposes. The top-
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Figure 46 – Custom dual matched die biopressure sensor prototype showing
absolute reference chamber and top-side dies therein.
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side chamber, as shown in Figure 46, provides a rigid absolute pressure
chamber, common to both dies, while another set of separate chambers provide
independent pressure ports for each bottom-side die, consistent with Figure 21.
Figure 47 shows one of the finished custom pressure sensors configured for
laboratory evaluation, identified as Build 0517, with an absolute pressure
chamber of approximately 28.92” Hg (9,987 mm H2O).
For operation, both of the sensors were biased at +5 VDC producing a nominal
zero pressure output of +2.5V. The output signals were amplified using an
Analog Devices AD8222 instrumentation amplifier for reasons described in the
Electronics Readout Overview section. The AD8222 was biased at ±10 VDC
whereby the nominal output voltage was zero for zero input pressure. Backside
die pressure produced a negative going signal in each sensor. However, the U1
output was measured positively with respect to the common mode point and U2
was measured negatively. Figure 48 shows a schematic of the front-end readout
circuitry used in laboratory measurements. Figure 49 shows the recorded
transfer function for the custom dual sensor build resulting from independent
backside die stimulation. Gain of U1, determined from the best-fit straight line,
was 10.92 mV/mm H2O while U2 was 10.64 mV/mm H2O. Linearity was found to
be 1.03% and 2.36% FSS, respectively. Zero offset for U1 was 1.65 mm H2O
and 3.41 mm H2O for U2.
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Figure 47 - Custom dual matched die biopressure sensor prototype showing both
independent chambers and top-side reference chamber.
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Figure 48 – Custom dual matched-die sensor readout circuit.
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Figure 49 – Custom dual biopressure sensor transfer function (Build 0517).
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The sensor die’s pressure range of ±500 mm H2O was confirmed in the custom
module, as shown in Table 5, with an absolute error of less than 1%. Figure 50
shows the acquired signal for +502 mm H2O revealing a standard deviation from
mean level for n=100 samples of 0.69 mm H2O. Likewise, Figure 51 shows the
acquired signal for -499 mm H2O with a similar standard deviation of only 0.72
mm H2O. Overall, the measured pressure range satisfies objective O3.1.
Table 6 tabulates resolution measurements for both dies given 3σ noise levels.
Noise levels were observed to increase with pressure until a plateau occurred
around 150 mm H2O. Overall, the 3σ resolution was 3.0 mm H2O for U1 and 3.4
mm H2O for U2, meeting the objective set forth in O3.2 of less than 10 mm H2O.
The limit of detection (LOD) was found from the noise at 0 mm H2O to be 2.3 mm
H2O for U1 and 3.3 mm H2O for U2. For levels above 200 mm H2O, the data,
including that from full range testing and Table 6, reveals resolutions of
approximately one percent or better.
For repeated accuracy measurements, including the measurement of both
trueness and precision, 150 mm H2O was selected for assessment since it
produced the worst noise figures over the sensor’s range (see Table 6). Table 7
provides accuracy statistics for n=100 samples while Figure 52 and Figure 53
show samples of measured signals. A maximum mean error of -3.73 mm H2O
between the two sensors was measured with U1. However, the error measured
was within the objectives of O3.3, or ±5 mmH2O.
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Table 5 – Sensor Pressure Range Verification

Vrms

Vrms
Offset

Gain
mV/
mm
H2O

Measured
Pressure
mm H2O

Actual
Pressure
mm H2O

Error
mm H2O

Error
%

+500 mm H2O

5.37

-0.0221

10.64

506.78

502

4.78

0.95%

-500 mm H2O

-5.38

-0.0221

10.64

-503.56

-499

-4.56

0.91%
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Figure 50 - +502 mm H2O signal

Figure 51 - -499 mm H2O signal
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Table 6 – Sensor resolution summary

U1

U2

Average
3σ
Resolution
mm H2O
mm H2O

Pressure
mm H2O

Noise, σ
mV

3σ
mV

0

8.1

24.3

2.3

100

7.7

23.2

2.2

150

13.5

40.5

3.9

300

13.2

39.7

3.8

0

11.5

34.5

3.3

100

8.1

24.3

2.3

150

16.3

48.9

4.7

300

12.0

36.1

3.5

143

3.0

3.4

Table 7 – Accuracy measurements for sensors U1 and U2, n=100

3σ
mm
H2O

Vrms

Vrms
Offset

Gain
mV/
mm H2O

Measured
Pressure
mm H2O

Actual
Pressure
mm H2O

Error
mm H2O

U1 150 mm H2O

1.59

-0.008

0.010925

146.27

150

-3.73

-2.48% 0.00105

0.29

U2 150 mm H2O

-1.57

-0.005

-0.01064

147.10

150

-2.90

-1.93% 0.00365

-1.03
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Error
%

σ
Vrms

Figure 52 – Accuracy measurement for sensor U1, 150 mm H2O, n=100 samples

Figure 53 - Accuracy measurement for sensor U2, 150 mm H2O, n=100 samples
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Manual power cycle tests were performed for 150 mm H2O to measure
reproducibility, or precision. Figure 54 shows the resulting histogram of 100
samples revealing a mean pressure of 151.29 mm H2O. The standard deviation
was 0.387 mm H2O with 3σ equaling 1.16 mm H2O. The range was 1.8 mm H2O
and the mean absolute error was 1.29 mm H2O. The reproducibility assessment
meets the precision objective of ±5 mm H2O of O3.4. Given the maximum error
for the worst noise figures measured over the range, the combined trueness and
3σ reproducibility results in an accuracy of 4.89 mm H2O. For pressures beyond
200 mm H2O, including 500 mm H2O, a maximum error of 3.8 mm H2O was
found with U1 at 300 mm H2O, or 1.26%, well within the objective of O3.5.
To explore the dual matched dies’ capability to mitigate gain and offset drift with
the system calibration described in Chapter Three, the sensors’ bridge bias and
common mode pressure was modulated. Bridge bias was adjusted from 80% to
100% (5 VDC) to 120% to induce sensor gain shifts of ±20%.
Figure 55 shows the resulting pressure-voltage transfer functions for the new
custom dual-die pressure sensor module. Both of the sensors’ gain response
was measured with a maximum gain difference between the two matched
sensors of +0.65% and -0.3% over the full range of 80% to 120% gain shift.
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Figure 54 – Precision measurement histogram for 150 mm H2O and n = 100
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Figure 55 - Dual sensor die comparison for 80%, 100%, and 120% gain.
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A hydraulic and pneumatic test system was setup according to that described in
Chapter Three. The laboratory setup is shown in Figure 56, Figure 57, and
Figure 58. The test system was designed to assess the custom dual matched
die system’s performance under induced gain and offset shift. Figure 56 shows
the test and measurement system, including a graduated burette simulating a
ventricular pressure source. Figure 57 shows the reference fluid column and 2L
water reservoir simulating the peritoneum. Figure 58 is the test setup’s vacuum
pressure chamber used for inducing an offset pressure relative to the sensor’s
integrated absolute pressure chamber. An enclosed input pressure source
consisting of a drying tube simulated ventricular pressure.

Figure 56 – Custom dual biopressure sensor system test bench.
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Figure 57 – Reference reservoir for liquid fluid column.

Figure 58 - Isolation pressure chamber with self-contained pressure source.
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The new dual matched-die pressure sensor module was subjected to gain drifts
of +20% and -20% to evaluate the system’s ability to accurately negate the error.
Barometric pressure (i.e. station pressure) at the time of testing was 29.138” Hg
(10,062 mm H2O), representing an offset of 75 mm H2O (10,062 barometric less
the integrated absolute chamber’s pressure of 9,987 mm H2O). The sensor
module’s reference fluid column was approximately 445 mm in length and the
height of the reservoir was measured upon each positioning from 0° to -90°.
Table 8 outlines the results of the custom sensor’s self-calibration utilizing its
reference fluid column.
For measurement series one, for example, an input stimulus of 100 mm H2O
(above barometric) was used to simulate ventricular pressure. A gain deficit
of -20% was induced for the test. A 440 mm reference fluid column was
connected to one of the two sensor dies (i.e. the reference die). For a patient
deployment, the reference column length would be recorded upon implant. The
system was then operated in calibration mode as if it were in-vivo. Signal
measurements were taken by placing the reference column in both the 0°
and -90° positions, as recorded in Table 8. The gain was then derived from
single-ended measurements of the reference die, as follows:

𝐴

0.449
4.110 𝑉
440 𝑚𝑚 𝐻 𝑂

0.008320455

𝑉
𝑚𝑚 𝐻 𝑂

Next, the offset was calculated, based on the gain, using slope-intercept form.
Barometric pressure was measured using the iPhone® Bosch BMP-280,
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Table 8 – System calibrated dual matched-die sensor results at gain ±20%

Measurement Series
Known Test
Parameters

1

2

3

4

5

6

4.00

5.00

6.00

4.00

5.00

6.00

80%

100%

120%

80%

100%

120%

100

100

100

150

150

150

10,033

10,039

10,038

10,038

10,038

10,038

-440

-444

-443

-444

-445

-445

0⁰ Position Signals
CSF (Vrms):
Ref (Vrms):

0.385
-0.449

0.621
-0.428

0.481
-0.799

0.769
-0.478

0.968
-0.611

1.390
-0.517

-90⁰ Position Signals
CSF (Vrms):
Ref (Vrms):

0.457
-4.110

0.597
-5.180

0.535
-6.390

0.848
-4.210

1.090
-5.260

1.310
-6.280

-0.0083

-0.0107

-0.0126

-0.0084

-0.0104

-0.0130

78%
83.03

-107.02

118%
125.89

80%
83.90

-104.26

124%
129.48

CSF Pressure (mm
H2O):

100.2

98.0

101.4

148.4

151.1

147.3

Error:

0.23%

-1.99%

1.42%

-1.10%

0.76%

-1.83%

Sensor Bridge Bias (V):
Sensor Bridge Bias
(%):
CSF Test Pressure
(mm H2O):
Barometric Pressure
(mm H2O):
Ref. Column Pressure
(mm H2O):

Derived Gain and
Offset
Measured Gain (V/mm
H2O):
Measured Gain (from
nominal):
Offset (V):
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providing a specified 0.10 mm H2O resolution and typical accuracy of 1.22 mm
H2O [136]. In a patient setting, the barometric pressure would be read ex-vivo
and equated to the reference die’s pressure reading in the supine, or 0° position,
whereby the column pressure would be approximately zero.

𝑏

0.449 𝑉

10,033 𝑚𝑚 𝐻 𝑂 ∗

0.0083205

𝑉
𝑚𝑚 𝐻 𝑂

83.03 𝑉

Finally, with the gain and offset derived from using the sensor system’s reference
fluid column and externally measured barometric pressure, the ventricular
pressure may be determined. The gain and offset values for the reference
sensor can be applied to the ventricular pressure sensor, by virtue of matched
dies, and intracranial pressure calculated as follows:

𝑃

𝑎𝑏𝑠

0.385 𝑉

83.03
𝑉
0.008320455
𝑚𝑚 𝐻 𝑂

10,033 𝑚𝑚 𝐻 𝑂

100.2 𝑚𝑚 𝐻 𝑂

The absolute value is taken due to the negative going signals arising from bottom
side die stimulation. As can be seen from this measurement series, the actual
versus derived CSF pressure resulted in an error of only 0.23% for a -20% gain
drift and a 75 mm H2O offset. Measurements were taken for ±20% induced gain
drifts with the same 75 mm H2O offset for both 100 and 150 mm H2O simulated
ventricular pressure. All measurements were within 2% of actual input pressure.
Table 9 provides the results of further inducing an offset using the

153

Table 9 - System calibrated dual matched-die sensor results for induced offset
Measurement #1
Sensor Bridge Bias (V):
5.00
Sensor Bridge Bias (%):
100%
CSF Test Pressure (mm
H2O):
150
Barometric Pressure (mm
H2O):
10061
Ref. Column Pressure (mm
H2O):
-254
Known Test Parameters

Measurement #2
5.00
100%
150
9810
-254

0⁰ Position Signals
CSF (Vrms):
Ref (Vrms):

0.805
-0.791

-1.45
-3.07

-90⁰ Position Signals
CSF (Vrms):
Ref (Vrms):

0.791
-3.491

---

Derived Gain and Offset
Measured Gain (V/mm
H2O):
Offset (V):

-0.01063
106.16

-0.01063
101.21

CSF Pressure (mm H2O):

150.14

152.40

Error:

0.09%

1.60%
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isolation/vacuum pressure chamber shown in Figure 58. A simulated ventricular
pressure of 150 mm H2O was used in both measurements. Measurement 1 was
taken outside the chamber to facilitate gain determination using the two different
reference column positions. The calculated gain and offset at normal barometric
pressure resulted in a CSF calculation of 150.14 mm H2O, almost precisely the
known true input. Measurement 2 was taken thereafter entirely within the
pressure chamber at a reduced environmental pressure of -9.9” H2O (i.e. -251
mm H2O) as shown in Figure 59. This resulted in an absolute environmental
pressure of 9,810 mm H2O. For Measurement 2, the system’s reference column
line was flat against the bottom of the chamber, representing the 0° position and
then the new offset was calculated. 90° signal measurements within the
chamber were not necessary, or feasible, as the gain was determined outside the
chamber. As can be seen from the table, the 150 mm H2O pressure voltage
shifted from +0.805 V to -1.45 V due to the environmental change. The derived
offset shifted from 106.16 to 101.21. Combined, the CSF pressure derived for
Measurement 2 within the chamber was 152.40 mm H2O, representing only a
1.60% error. The test demonstrates the ability of the sensor system to correct
large baseline shifts. Without the offset correction, the resulting error would have
been over 100%.
Figure 60, Figure 61, and Figure 62 graph the test results of the system
calibrated custom biopressure sensor. For 150 mm H2O and either a gain of
±20% or offset of approximately 250 mm H2O, the maximum error from true
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Figure 59 – Vacuum pressure chamber measurement
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Figure 60 – System calibrated dual sensor performance for 100 mm H2O and
induced gain shift.
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Figure 61 - System calibrated dual sensor performance for 150 mm H2O and
induced gain shift.
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Figure 62 - System calibrated dual sensor performance for 150 mm H2O and
induced offset shift.
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ventricular pressure was 2.75 mm H2O, or 1.83%. For 100 mm H2O, the
maximum measured error was 1.99%. The system meets the objectives of O4.3
for gain and offset correction. Furthermore, for the extent of gain and offset
induced and the corresponding calibration results, the sensor is anticipated to
correct drift to within ±50 mm H2O over its expected service life per O5.1.
Although the research focus of this work is upon the system calibrated
biopressure sensor and interface, as outlined in Figure 26, requirements were
nevertheless considered in R4.0 that the sensor support non-invasive readout.
The power consumption, signal levels, and geometry all come under
consideration to facilitate such an implantable non-invasive readout system.
Figure 26 illustrates one potential system design employing the Texas
Instruments® TE CC2541 for providing Bluetooth Low Energy communications to
and from the transponder. The CC2541 additionally integrates a 12-bit analogto-digital converter (ADC) supporting an input range from 0 to 3.6 V. The
laboratory front-end circuit given in Figure 48 can be modified to support the
CC2541’s ADC by reducing the gain of the instrumentation amplifier (IA).
Although the laboratory’s front-end circuit could be passively or actively
attenuated to optimize the circuit’s signal to noise ratio, doing so would consume
additional power. Provided the sensor signal is amplified close to the die,
reducing the IA may be the best compromise to preserve power consumption.
Figure 63 shows the schematic of the reconfigured front-end circuit biased by a
common positive rail of +5V with a reference of 1.54V to shift the output of the IA
to support both positive and negative pressure signals. The sensor’s +5V bridge
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Figure 63 – 5V front-end circuit design with Vo of 0-3.08 V supporting TI CC2541
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bias is the same as that used by the sensor’s laboratory testing. The IA output
range is designed in the circuit to support -1,000 mm H2O to +1,000 mm H2O
over a 0 to 3.08V range with 1.54V representing the zero-pressure signal level.
Therefore, the sensor’s front-end electronics can be configured for compatibility
with the TI CC2541 ADC per O4.1.Operating power consumption of the primary
components outlined in Figure 25 was calculated and is shown in Table 10.
Altogether, the custom dual matched-die transponder providing Bluetooth LE
communications and wireless inductive powering is calculated to consume
roughly 146 milliwatts. The amount of power that can be safely transmitted
transcutaneously into humans has been studied and outlined by the Institute of
Electrical and Electronic Engineers (IEEE) in standard C95.1 [137]. Maximum
permissible exposure (MPE) for the general public in the frequency range of
Bluetooth 4.0 or 5.0 (i.e. 2.4 GHz) is limited to 10 watts per square meter
averaged over 30 minutes.
Sampling of the biopressure sensor transponder in two patient positions is
anticipated to consume no more than 30 seconds of powering and
communications in total (assuming one ICP sample per 30-minute period). With
respect to the power transmission exposure area, the TI BQ500210EVM, as an
example Qi transmitter, utilizes a 44 mm diameter coil, resulting in an area of
6,079 mm2. The total permissible power transmission for this area, according to
the standard, is 60.8 mW averaged over thirty minutes. Equivalently averaging
this limit over 30-seconds of a 30-minute period results in 3.648 W, which is 25x
162

Table 10 – Power consumption of transponder’s main components.
Power
(mW)

Notes

Sensor Die 1

8.3

At 5V bias.

Sensor Die 2

8.3

At 5V bias.

U1 IA

5.5

At 5V bias.

U2 IA

5.5

At 5V bias.

TI CC2541

60.1

In active transmit mode.

STWLC04

58.5

60% efficiency

Total:

146.2

milli-watts
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the power estimation tabulated in Table 10 for the transponder. Therefore, the
transponder’s power requirements for transcutaneous transfer meets the safety
limits of IEEE C95.1 as specified by O4.2.
pressure upon a resting hydrophobic surface. At any liquid-gas interface, a
molecule residing at a free surface of the liquid will encounter a weaker binding
energy than that within the bulk, thereby resulting in a net positive surface
energy. For water, this surface energy is 72 milli-Joules per square meter (or
milli-Newtons per meter) at 25°C. To minimize the liquid’s surface energy state,
higher energy surface molecules are minimized via cohesive intermolecular
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Table 11 outlines the main component volumes for the transponder comprising a
PCB substrate, sensors, readout electronics, power reception and regulation
electronics, Bluetooth LE transceiver, and antenna component. The volume
consumed is just under 3,000 mm3. The maximum volume of a typical CSF
reservoir dome indicated by O2.1 is 3,464 mm3. Therefore, the biopressure
sensor’s transponder components meets the objectives of O2.1 with volume
remaining.

Non-Ideal Effects and Challenges
During the course of this research numerous challenges arose with most being
related to the measurement of very low pressures and challenges with small
scale fluid transfer. Pressures distinguished by this work were on the order of 1
mm H2O. Due to surface tension, a mere drop of water typically poses twice this
pressure upon a resting hydrophobic surface. At any liquid-gas interface, a
molecule residing at a free surface of the liquid will encounter a weaker binding
energy than that within the bulk, thereby resulting in a net positive surface
energy. For water, this surface energy is 72 milli-Joules per square meter (or
milli-Newtons per meter) at 25°C. To minimize the liquid’s surface energy state,
higher energy surface molecules are minimized via cohesive intermolecular
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Table 11 – Transponder primary component volumes

Component

X
mm

Y
mm

Z
mm

Substrate

15.00

29.00

1.57

683.0

Sensor Die 1

2.10

2.10

0.65

2.9

Sensor Die 2

2.10

2.10

0.65

2.9

U1 IA

4.10

4.10

0.80

13.4

U2 IA

4.10

4.10

0.80

13.4

TI CC2541

6.15

6.15

1.00

37.8

STWLC04

3.09

4.70

0.55

8.0

Antenna (DIA)

33.00

33.00

0.64

2198.5

Total:

2,960 mm3
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Volume
mm3

forces, resulting in minimal surface area. These internal surface forces are
referred to as surface tension. Surface tension can easily result in several
millimeters of water pressure in a closed system. The capillary effect, resulting
from both cohesive intermolecular forces and adhesive forces to a surrounding
vessel, is known to lift the sap in trees and plants several meters. While the
benefits of these properties are abundant and critical, their effect can be
detrimental in a low pressure measurement system.
As an example, Figure 64 shows the effects of initial outgassing from polyvinyl
chloride (PVC) tubing used to hydraulically couple a liquid pressure source to
one of the pressure sensors studied. While these bubbles certainly have a
limited impact upon occupying volume within the system and increasing the
liquid’s pressure, they have not yet maximized their effect. With time, on the
order of 24 hours, the microbubbles aggregate into air pockets making full
contact with the interior circumference of the tubing as shown in Figure 65. At
this point, surface tension and capillary effects take their toll upon accurately
measuring the system’s desired liquid pressure reservoir. Their effect reduces
the reservoir pressure sensed by the sensor. Additionally, surface tension
effects at edge interfaces were examined to withstand relatively large pressures
before translating head pressure to the system.
The most challenging of air pockets was within the sensor die itself and its
mating ceramic through-hole. Although the volume is estimated at only little
more than 1 mm3, as tabulated by Table 12, the resulting moisture transfer
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Figure 64 – Initial outgassing of polyvinyl chloride (PVC) tubing.

Figure 65 – Bubble formation and air voids from advanced outgassing of tubing.
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Table 12 – Sensor and supporting substrate cavity volume.

Cavity

L (mm)

W (mm)

H (mm)

Radius
(mm)

Volume
(mm3)

Ceramic Through-Hole

--

--

1.000

0.362

0.412

Chip Support

--

--

0.257

0.362

0.106

1.487

1.487

0.335

--

0.741

Total:

1.258 mm3

Si sensor

caused very non-linear and unstable pressures. Figure 66 charts the air-liquid
transfer that began to occur within the first several days of pressurizing the BLVR
sensor with liquid. The data shown was acquired using a National Instruments
DAQ system utilizing a sampling period of one-minute. Corresponding
observations of bubble formation are superimposed on the graph.
As can be seen from the graph, a sharp increase in pressure of approximately 13
mm H2O occurs upon the initial condensation of liquid occupying the unwetted
silicon cavity. A slight convex expansion of gas can next be observed just
covering the sensor port. The following exponential response results from the
slow fluid transfer occurring between the sensor’s bottom-side air cavity and the
liquid pressure chamber.
Air-liquid transfer was observed over five distinct phases, and the process is
hypothesized as follows:
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Figure 66 – Sensor cavity air-liquid transfer and bubble formation.
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1. The initial air-liquid boundary interface, whereby surface tension and the
air cavity’s counterpressure counteract the liquid’s hydrostatic pressure,
maintains near-term equilibrium.
2. Water vapor transfer resulting from unequally bonded surface molecules
on the liquid’s surface concentrates within the chip’s air cavity and
condenses, resulting in initial mass transfer and air displacement. In this
phase, pressure sharply increases, and a surface bubble begins to form
on top of the ceramic substrate’s port hole. Vapor transfer increasingly
alters at this point due to the increased pressure within the air cavity.
3. Continued liquid mass transfer occurs resulting in a growing gas bubble
with increased interior pressure yet with surface tension preventing
complete displacement.
4. Additional accumulating water vapor condenses inside the pressure
sensor’s cavity further displacing air and increasing the size of the bubble.
The bubble then extends beyond the circumference of the ceramic port
hole and forms an underside curvature that results in a growing buoyant
force due to the liquid’s pressure gradient from the bottom of the spherical
shape to the top. Although pressure within the sessile bubble increases,
as evident by the diameter of the bubble versus the hydrostatic exterior
pressure, the bubble’s upward buoyancy force reduces pressure within the
sensor’s cavity.
5. Once buoyant forces exceed the partial bubble’s surface tension forces
surrounding the circumference of the pressure port, then the air pocket
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ascends in the form of a complete sphere. Spherical shape is maintained
upon evacuation whereby liquid water minimizes its surface energy
counterbalanced by the positive pressure within the air bubble. At this
point of equilibrium, distributed contraction forces equal the bubble’s
interior pressure by the Young-Laplace law [138]:

∆𝑝

2𝛼
𝑟

where Δp is the difference in pressure from within the sphere versus the
exterior for a given bubble radius, r, and where α is the surface energy (or
tension), which for water is approximately 70 mJ/m2 (or 70 milliNewtons/m) at 37°C. Relative positive pressure exists toward the center
of curvature.
Steps 1 through 5 repeats until the entire cavity is at final equilibrium with stable
pressure.
To gain further insight into this process a COMSOL Multiphysics simulation was
undertaken. A 2-D axisymmetric two-phase flow, phase-field, study with heat
transfer and moisture transport was setup for the sensor geometry under 4 mm
of water pressure. The model utilized the Cahn-Hilliard equation with a chemical
potential to represent the diffuse interface between the immiscible liquid and air
domains. The Navier-Stokes equations were used for fluid transport and
conservation of mass. Wetted walls were used for simulating surface tension or
capillary effects encompassing a glass pressure cylinder atop the sensor’s
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ceramic substrate and the silicon support structure and sensor itself. The heat
transfer from the sensor to the liquid was modeled by convection in moist air, as
shown in Figure 38. Initially, the liquid pressure chamber contained 4 mm of
water with a hydrostatic pressure of ρgz at the sensor’s inlet port. The initial
conditions for the sensor’s port cavity was set to 40% humidity. Environmental
conditions were set to 1 atmosphere at 37°C. Figure 67 reveals the pressure
gradient after 90 minutes showing the pressure presented to the surface of the
sensor, without any bubble formation, is indeed 4 mm H2O.
The concentration of water vapor at 90 minutes is shown in Figure 68 with
approximately 2.43 moles of water vapor, or 99.76% relative humidity. The
difference in dew point and the cavity’s ambient temperature under this pressure
is only -0.05°C before condensation occurs. Figure 69 shows the water volume
fraction of the assembly revealing only partial liquid penetration into the cavity
under surface tension resistance. Figure 70 shows the corresponding fluid
velocity of very small volumes at 100 to 250 microns per second. Convergence
beyond 90 minutes for the multiphysics model was not achievable.

173

Figure 67 – COMSOL axisymmetric pressure gradient.

Figure 68 - COMSOL axisymmetric water vapor concentration.
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Figure 69 - COMSOL axisymmetric water volume fraction.

Figure 70 - COMSOL axisymmetric fluid velocity.
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A re-setup of the model to include various forms of partial spherical microbubbles
in contact with the ceramic substrate’s port hole was unsuccessful at modeling
the actual observed behavior. The intent of the bubble simulation was to
evaluate fluctuating pressures produced within the sensor’s cavity. However,
within milli-seconds, the simulation collapsed the bubble and generally returned
to the state of the prior model. It was therefore not possible to model the full
behavior, including partial bubble formation adhered to the substrate, over
several days. Nevertheless, the COMSOL simulation provided insight into the
cavity’s pressure in the absence of a bubble and to convey the extent of water
vapor concentration within a short period of time.
Further challenges with air pockets were encountered beyond outgassing and
air-liquid fluid transfer. Nucleation of microbubbles from entrained air was
common with fresh water. The bleeding of air from small crevices and other
cavities also had to be overcome. As can be seen in the lower right-hand
quadrant of Figure 64, a venting port, later sealed with a viscous hard glue, was
used to initially bleed the system. Unfortunately, each of these air voids would
result in compression and potentially alter the baseline measurement of the fluid
column’s pressure as pressure was increased (such as in transfer function
testing). By the Ideal Gas Law, pressure and volume have an inverse
relationship, thereby as more pressure was added to a burette source, any
downstream air pockets would compress and shift the total column of liquid,
resulting in non-linearity in the measurement. For measuring transfer functions,
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resolution, and other measurements, shifts of only a few millimeters could have
significant impact. Therefore, it became paramount to eliminate gas sources
such as entrained air in test liquids. Materials with significant outgassing was
either eliminated (e.g. PVC), minimized via surface area, or mitigated though
vent ports until outgassing diminished (e.g. epoxied materials).
Additional challenges early in the research ensued with top-side liquid media
contact. Figure 71 shows a microphotograph of metal migration eventually
resulting from distilled water testing, which quickly turned conductive. The allure
of top-side liquid sensing was the alleviation of challenges with the bottom-side
sensor cavity as described above. Some manufacturers, such as TE
Connectivity, conduct top-side die biosensing with the use of a dielectric silicone
gel for fluid isolation. However, the TE Connectivity device earlier described is
limited to 72 hours use, likely in part due to the permeability of the gel.
Further PV=nRT effects were encountered by the custom dual biopressure
sensor’s absolute pressure chamber. The chamber is shared by both top-side
dies, as shown in Figure 21 and Figure 45, and is temperature sensitive. The
volume of the top-side chamber is approximately 180 mm3. For a chamber
sealed at standard atmospheric pressure and 21°C, the number of moles of air
within the chamber equates to 7.46 micromoles. Under normal circadian
fluctuations in brain temperature of 0.2°C, this results in only 7 mm H2O change
over the period. Given the biopressure sensor’s deployment, which is intended
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Figure 71 – Top-side die metal migration from liquid media contact.
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to encounter only very short timeframes between two position calibration
measurements, temperature fluctuation is of low concern. However, during
thermal chamber testing in the laboratory, large temperature shifts occurred
during the opening and closing of the chamber’s door, which was captured in
data acquisition, as shown in Figure 72.
Figure 72 shows the converted pressure read by each pressure sensor, U1 and
U2. The setup for this particular snapshot of data was that each die had
individual bottom-side pressure stimuli of equal pressure. However, due to fluid
transfer earlier described, this particular acquisition period revealed an offset
between the two dies. Furthermore, a large offset was induced by the change in
temperature of the absolute pressure chamber from room temperature
construction to chamber testing, resulting in absolute pressure readings much
higher than otherwise expected. In essence, this snapshot of data altogether
captures several of the non-ideal effects encountered.
Of particular relevance was the change in pressure for both dies resulting from
the change in temperature of the chamber door opening. For U2, for example,
the pressure reading just prior to opening the chamber door was 309 mm H2O
with a temperature probe in the chamber reading 36.25°C (the chamber’s
standard sensor read 37.0°C). One minute after opening the door, the
temperature probe read 26.79°C and the pressure reading increased to 664 mm
H2O (+355 mm change). While it would intuitively seem that the pressure
reading should drop with a reduction in temperature, it should be noted that the
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Figure 72 – Custom dual biopressure sensor absolute reference temperature
response.
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pressure chamber stimulates the top-side of both dies counteracting bottom-side
liquid stimulation. Therefore, a drop in top-side pressure from a reduction in the
absolute pressure chamber’s pressure would equivalently result in an increased
pressure reading bottom-side. The ideal gas law predicts a shift of 334 mm H2O
for the chamber’s 9.5°C cooling. However, a shift of only 0.6°C further matches
the measured 355 mm H2O change, which is conceivable given the temperature
probe was not placed directly onto the sensor’s reference chamber, but further
interior to the thermal chamber.
Additional consideration to the absolute pressure reference is necessary with
respect to barometric pressure shifts. Similar to the effect of a large temperature
swing upon the reference’s pressure is the opposite effect of a large commonmode pressure swing to bottom-side sources such as that under atmospheric
pressure shifts. As described in the Sensor System Design section, extreme
barometric pressures can span from 8,872 mm H2O on the low end up to 11,472
mm H2O on the high end, a 2,600 mm H2O range. Further to this point, on an
airline flight, environmental pressures were recorded that spanned from 10,298
to 8,375 mm H2O between near sea-level take-off to a cruising altitude of 9,449
meters (31,000 feet), a difference of 1,923 mm H2O. However, the former
weather pressure metrics were under extreme conditions and from world records
such as a cyclone’s interior pressure. The latter pressure range, taken during
flight, was under conditions untypical of measuring ICP. Nevertheless, the
sensor dies utilized within this research have a burst pressure of over 20,000 mm
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H2O and a proof pressure of 5,080 mm H2O. During the course of this work, no
non-linearity effects upon the sensors transfer function was observed, even
under induced offset testing. As a more practical range, over the almost threeyear period sensor testing was conducted, local barometric pressure conditions
varied a maximum of 535 mm H2O. In any event, should a further increase in
tolerance to very large environmental pressure swings become necessary,
matched pressure sensor dies could be fabricated at the potential expense of
resolution.
Altogether, the non-ideal effects encountered by this research were
surmountable. Solutions to many of the problems was to simply avoid or
evacuate air intrusion into the system. Additionally, sufficiently large diameter
lumens were employed where there was a free surface that would otherwise
allow any surface tension or capillary effects to occur. Bottom-side die stimulation
was used versus top-side for liquid media compatibility. Fluid transfer into the
bottom-side cavity was eliminated by micro-positioning 30-gauge needles to prewet the cavity. Glass cylinders or tubing was utilized to eliminate outgassing.
Where outgassing could elsewhere occur, material choices were made to
minimize the impact or was otherwise allowed to stabilize prior to use.
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CHAPTER FIVE
CONCLUSIONS AND RECOMMENDATIONS
In summary, chronic intracranial hypertension, or hydrocephalus, is a debilitating
condition that affects millions of people. Prior to shunt treatments in the 1950’s
hydrocephalus was typically fatal. Shunts are life saving devices, but have yet to
be perfected and, as a result, have about a 50% failure rate by their second year
of implant. The typical onset of symptoms for hydrocephalus often begins with a
headache which can shortly thereafter lead to fatal consequences without
intervention. The same is true for a failed shunt and nearly all shunted patients
undergo a surgical revision for replacement by year 10. Such headaches are not
only associated with escalating hypertension, however. Shunts often under- or
over-drain CSF, particularly under siphoning conditions, which also presents with
a headache. Therefore, headaches for hydrocephalus patients are not always
indicative of a forthcoming life-threatening emergency. The conundrum is, short
of invasive procedures, there are currently no accurate means of measuring ICP
to understand if a shunt has failed, needs adjustment, or if a headache is
otherwise benign. Patients, well aware of shunt failure rates and the ensuing
consequences frequently undergo ionizing imaging diagnostics. Such imaging is
often inconclusive, and patients next undergo invasive techniques for assessing
or revising their shunt. Billions of dollars are spent each year on the diagnostics
and treatments of hydrocephalus when many of these costly procedures could be
reduced with non-invasive and non-ionizing diagnostics for measuring ICP.
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Similar to arterial blood pressure diagnostics, which are easily and reliably
performed in a patient’s home, a non-invasive means of quantitative ICP
measurement would allow early alerts of escalating ICP and further enable
hydrocephalus shunt valve optimization. Clearly, the need exists for such a
diagnostic device and researchers have cited a long-standing need for telemetric
ICP technology.
As found from a survey of the literature, drift in pressure measurement accuracy
has been, and remains, the inhibiting factor to enabling a viable long-term
implantable ICP device. Offset error has been identified to frequently occur from
a change in ex-vivo to in-vivo temperatures upon implant. Gain error, however,
has been found multifactorial, yet with thermally induced packaging stress as the
predominant factor. Other degradations include bonding damage, oxidation
growth, and the deterioration of an integrated circuit’s photo-resistive layer. A
recent study concluded that sensor drift was largely unpredictable, making
deterministic compensation techniques challenging. Evaluations conducted over
several years of this research found even the most sophisticated driftless
commercial devices drift in excess of 20% and with large unpredictable shifts.
The research herein has resulted in a new, novel, and patented diagnostic
approach to mitigating both offset and gain drift in low-pressure liquid-media
sensing. The approach exploits the effect of gravitational siphoning in shunt
systems to provide a means for gain and offset calibration. By utilizing two
independent, yet matched, silicon sensor dies, known pressure changes in one
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bio-compartment can be used for calibrating sensor measurements in another,
such as the brain. The work herein included construction of the new device and
the evaluation of crucial performance aspects necessary for long-term ICP
measurement.
Several custom dual biopressure sensors were constructed and tested over the
course of this research. As outlined in Chapter Three’s Requirements, a number
of research objectives were established for evaluating the new sensor. Table 13
provides the keyed objectives which were traced throughout Chapter Four’s
Results and Discussion.
O1.1 – 1.3 relate to the overall requirement that the implantable biopressure
sensor provide biocompatible interfaces. The results from Chapter Four
examined the materials of the new sensor as well as materials that may be used
in conjunction with the sensor dies. Overall, the materials were referenced to
prior studies showing strong biocompatibility and hermeticity suitable for
sterilization and implant in humans.
O2.1 relates to the requirement that the overall transponder be geometrically
compatible as a cranial implant. A very standard device geometry, currently in
clinical use, was selected to compare its volume with that of the sensor’s overall
transponder components. Chapter Four tabulated the results and demonstrated
fulfillment of the objective.
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Table 13 – Research Objective Fulfillment

Research Objectives
O1.1

O1.2

O1.3

O2.1

Justification of sensor to present a bottom-side
bulk micromachined monocrystalline die
surface for the pressure diaphragm to meet
biocompatibility. Die must be capable of
bonding to suitably hermetic biocompatible
materials. Sensor must withstand sterilization
method(s).

✓

Device to be capable of sustaining a
compatible wash and autoclaving, ethylene
oxide, or gamma radiation sterilization without
damage.

✓

Surfaces to be capable of hermeticity to meet
the intended service life of the implant.

The sensor's transponder components must be
capable of being contained within a typical CSF
reservoir's volume (34 mm diameter and
7.2mm height) for suitable implantation below
the scalp, yet above the skull, with pressure
communication through a cranial burr hole.

O3.1

Sensor must provide a pressure range from 500 mm H2O to +500 mm H2O.

O3.2

Sensor must provide a 10 mm H2O resolution,
or less, up to 200 mm H2O and within a 10%
maximum beyond.

O3.3

Fulfillment

Sensor must provide a maximum accuracy (or
trueness) of ±5 mm H2O.

✓
✓
2,960 < 3,464 mm3
Limit

✓
✓
3.4 mm H2O

✓
3.73 mm H2O

O3.4

Sensor must provide a maximum precision of
±5 mm H2O.

✓
1.16 mm H2O
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Table 13 (continued)

Research Objectives
O3.5

O4.1

O4.2

The sensor must overall provide a combined
maximum accuracy (incl. precision) of ±10 mm
H2O.over a ±200 mm H2O range and 10%
maximum beyond.
Buffered sensor output must be capable of
providing a signal within a 0 - 3.3 volt range for
interfacing to the Texas Instruments CC2541
ADC and Bluetooth LE system-on-chip.
The estimated power consumption of the
sensor's transponder must be less than that
which can be transcutaneously transmitted
safely per IEEE Standard for Safety Levels with
Respect to Human Exposure to Radio
Frequency Electromagnetic Fields, C95.1.

O4.3

The sensor must be capable of gain and offset
calibration to meet the specified accuracy.

O5.1

Expected drift over the device's intended
service life must be less than ±50 mm H2O.

Fulfillment

✓
4.89 mm H2O

✓
0 - 3.08V

✓
0.146 < 3.648 W Limit

✓
✓
Correctable to within
2.75 mm H2O
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O3.1 – 3.5 stem from the requirement that the sensor provide clinically
acceptable ICP resolution and accuracy. Each objective was justified within the
context of clinical literature for providing diagnostics to hydrocephalus patients.
The pressure range, resolution, and accuracy were all demonstrated by the new
custom device to fulfill the objectives.
Objectives O4.1 – 4.3 relate specifically to the sensor’s ability to support noninvasive calibration and readout. The sensor and front-end electronics were
shown compatible with a prevailing wireless Bluetooth LE system-on-chip (SoC).
Additionally, the power consumption of the sensors and transponder components
were shown to be within safe limits for transcutaneous powering. Finally, both
objectives O4.3 and O5.1 were satisfied with data demonstrating the new
device’s capability for self-calibration to mitigate large gain and offset drifts to
within 3 mm H2O.
In conclusion, a survey of the literature and of the most recent technology
indicates that measurement drift over time is the limiting factor to enabling longterm implantable ICP monitoring. Research herein pursued a means of reducing
and overcoming such drift. A new novel patented device and calibration method
thereof utilizing matched-dies with dual references to mitigate drift was
developed and evaluated. The device and method demonstrated the ability to
negate large shifts in gain and offset in the laboratory to within a few millimeters
of water pressure, showing promise for in-vivo application. Future research will
seek to replicate the sensor system and performance in-vivo in an animal model.
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